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ABSTRACT 
  
Background/Introduction: Individuals with agrammatic Broca’s aphasia 
frequently are treated at single word level, verb priming, or simple sentence 
structure treatments. In this study, an impairment specific treatment such as 
Verb Network Strengthening Treatment (VNeST) was explored as well as a 
social functional approach such as Script Therapy. These two approaches 
were assessed by the outcome measures of rate of speech, subject-verb-
object production, and error rates during probe tasks.  
Objective: To examine the impact of two treatment approaches: Script 
Therapy and Verb Network Strengthening Treatment for two individuals with 
chronic agrammatic Broca’s aphasia. 
Method: A single subject multiple baseline alternating treatment across 
participants’ design was implemented. Each participant received each therapy 
for 9 weeks and both treatments were counterbalanced. Generalization 
probes were administered on the second session of each treatment per week 
to assess pre-to-post outcome measures including rate of speech, subject- 
verb-object production (SVO), and error rate. Effect sizes were calculated for 
baseline through maintenance outcome measures. To analyze the inter-
therapeutic effects of the two treatment, the Percentage of data Exceeding 
the Median was used.  
 
 
xi 
 
Results: Both participants improved over the 18 weeks on rate of speech and 
subject verb-object (SVO) production during probe tasks. For P1, Error rates 
decreased from baseline to maintenance phases. Effect sizes were calculated 
for the baseline to maintenance phases using the Busk & Serlin’s d2 formula 
(1992). The effects size calculations were compared using the Beeson & 
Robey (2006) benchmarks for lexical and syntactic metanalyses for aphasia.  
For the baseline to maintenance effects, small effect sizes were found for 
both participants for rate of speech. For P1, a medium to large effect was 
noted for SVO production. P2’s effect size for SVO production revealed no 
effect. Error rates for P1 revealed no effect. P2’s error rate produced a small 
unfavorable effect.  
Conclusions: Both participants benefitted from the two treatment 
approaches in individual ways. It is possible that the multi-modal nature of the 
training between VNeST and Script that engaged functional sentence 
production and a linguistic approach for sentence production contributed to a 
positive language change for these participants.   
Keywords: Impairment specific approach, social functional approach, 
agrammatic Broca’s aphasia, Verb Network Strengthening Treatment, Script 
Therapy  
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Chapter I 
 
INTRODUCTION 
 
Aphasia is an acquired neurogenic language disorder affecting the 
production or comprehension of speech and possibly ability to read or write 
(Cherney, Halper, & Kaye, 2008).  It can be caused by damage to the brain, 
often as a result of stroke or traumatic brain injury. Commonly in aphasia, the 
damage occurs mostly in the left cerebral hemisphere. In some cases, 
aphasia can affect the expressive and receptive components of language as 
well as reading and writing. In conjunction with the linguistic aspects of 
language, aphasia can also affect the social aspects of language leading to 
social isolation and reduced participation in life activities (Bilda, 2011). 
Aphasia often has profound effects on communicative interactions for 
both everyday activities and exceptional life experiences. The inability to 
access fluent and accurate language in routine daily interactions can have 
tangible practical and psychosocial consequences. For individuals with 
aphasia, life responsibilities that require particularly efficient language 
production such as interviewing for a job may seem beyond reach.  
Speech-language therapy for individuals with aphasia has 
predominately focused on single aspects of language recovery including word 
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retrieval and naming. Single aspects of language therapy have ranged from 
simple cloze phrase word retrieval tasks to canonical and non-canonical 
sentence production (Ballard & Thompson, 1999; Edmonds & Babb, 2011; 
Edmonds, Nadeau, & Kiran, 2009; Martin, Fink, & Laine, 2004). For this 
population, the specific treatments that target individual aspects of language 
at the word or sentence level are necessary; however, it is critical to address 
more functional communicative methods.   
This study compares two well-known treatment methods for 
agrammatic Broca’s aphasia: Verb Network Strengthening Treatment 
(VNeST) and Script Therapy. Both treatment options stem from a different 
aspect of language. VNeST focuses more on the building of the linguistic 
levels such as subject, verb, and object phrases. Alternatively, Script therapy 
focuses on the scripting of personal sentences to enhance functional 
communication. Previous studies with agrammatic Broca’s aphasia failed to 
examine a linguistic approach such as VNeST when compared to a functional 
treatment approach such as Script therapy.  A comparative study of these 
methods will reveal which method of treatment is more efficacious. 
  In daily clinical routine, clinicians are compelled to choose their 
methods of treatment to provide cost-effective treatment to patients with 
aphasia. Although the methods under scrutiny, in this study, have the same 
common objective of enhancing fluency in language production, these two 
methods originate from different theoretical backgrounds: VNeST works at a 
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more basic linguistic level of verb training and expects mastery at this level 
will generalize to connected speech/natural language production, whereas the 
‘Script’ treatment trains language production at a higher level, namely, 
discourse or Script.  
Thus, the outcome of the current study will have implications for these 
theoretical view points on how to achieve fluent language production in 
agrammatic aphasia. The comparison of these two treatments in this study 
has not been previously researched with individuals with agrammatic Broca’s 
aphasia. The relative cost of each treatment is inexpensive and both have 
merits at improving language in this population. Therefore, the purpose of this 
study is to examine and compare both treatments to one another and to draw 
conclusions about the relative benefits of each treatment. In doing so, the 
merits of each can be combined to provide individuals with aphasia with cost 
effective therapeutic interventions that improve language.  Additionally, it is 
also important to determine which therapy: VNeST or Script is more effective 
in promoting grammatically correct language for individuals with agrammatic 
Broca’s aphasia.  
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Chapter II 
 
LITERATURE REVIEW 
 
Aphasia: Fluent vs. Non-Fluent  
  There are two primary types of aphasia: fluent and non-fluent. Fluent 
aphasia can be characterized by impairments in the reception of language, 
with difficulties in auditory verbal comprehension or in the repetition of words, 
phrases, or sentences spoken by others. An individual with fluent aphasia’s 
speech is often easy and fluent, but there are difficulties related to the output 
of language such as production. Non-fluent aphasia can be characterized by 
difficulties in the articulation and production of language, but in most cases 
there is relatively good auditory verbal comprehension (Clark, Charuvasta, 
Miller, Shapiro, & Mendez, 2005). Chronic non-fluent aphasia is a lifelong 
handicap that can often lead to social isolation, loss of autonomy, and 
restricted social activity (Bilda, 2011). 
To define the nature of non-fluent language production, investigators 
have defined non-fluent speech as interrupted, awkwardly articulating with 
great effort. Additionally, non-fluent speech as marked by difficulty with 
articulation and long runs of words in a variety of grammatical constructions 
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(Gordon, 1998).  To further explain non-fluent and fluent speech, researchers 
have used quantitative and qualitative measures such as speech rate, 
pausing, phrase length, error production, self-correction attempts, semantic 
content, syntactic content, and grammatical form (Ballard & Thompson, 1999; 
Kiran & Thompson, 2003; Peach & Wong, 2004.) Fluent language production 
can be determined by a number of linguistic factors including the ability to 
produce appropriate morphology, lexical retrieval, sentence production, 
grammatical form, and conversational exchanges (Ballard & Thompson, 
1999; Edmonds & Babb, 2011; Edmonds, Nadeau, & Kiran, 2009; Martin, 
Fink, & Laine, 2004; Nickels, 2002; Raymer & Ellsworth, 2002) 
Agrammatic Broca’s aphasia  
When defining the nature of agrammatic Broca’s aphasia, it can be 
characterized by agrammatism or telegraphic speech, as well as deficits, in 
morphology, lexical retrieval, syntax, and discourse or conversation. Typically, 
individuals with Broca’s aphasia present with relatively intact comprehension.  
A patient with agrammatic Broca’s aphasia speech production is 
characterized by slow, halting speech, phonemic paraphasias, anomia, 
recurring utterances or perservations, articulatory impairments, and possibly 
apraxia of speech. Additionally, other aspects of language including the ability 
to produce sentences can be impacted with agrammatic Broca’s aphasia.  
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Sentence Production Deficits 
Agrammatism is characterized by an inability to construct a 
grammatical or intelligible sentence while retaining the ability to verbally 
produce single words (Jacobs & Thompson, 2000). Individuals with 
agrammatism present with an inability to speak grammatically because of 
brain injury or disease, usually with simplified sentence structure and errors in 
tense, number, and gender. Furthermore, individuals with agrammatism 
present with difficulty comprehending and producing semantically correct 
sentence. An example of agrammatic speech would be “Well…woman 
and…..dishes .um, well, um…forget it”. Treatment options for agrammatic 
aphasia vary with severity levels. Some treatments address training language 
at the verb level. For example, Treatment of Underlying Forms (TUF) is an 
approach that focuses on complex, non-canonical sentence structures and 
operates on the premise that training underlying, abstract, properties of 
language will allow for sentence production (Thompson & Shapiro, 2005). 
Sentence production deficits in patients with agrammatic Broca’s aphasia 
appears to be efficacious when the lexical and syntactic properties of (a) the 
language deficit exhibited by the aphasic individuals and (b) the sentences 
selected are for treatment and generalization. 
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Morphological Deficits  
One of the hallmarks of agrammatic-type Broca’s aphasia is a deficit in 
the production of functional morphology (Thompson & Shapiro, 2005).  
Individuals with agrammatic Broca’s aphasia may exhibit impaired lexical 
processing which greatly impedes their ability to construct sentences and 
communicate fluently. Morphology is defined as the study of internal word 
structure and the way morphemes combine to form words (Lee, Mack, & 
Thompson, 2012). Accordingly, individuals with agrammatic Broca’s aphasia 
exhibit difficulty in understanding or producing complex lexical items that can 
be characterized as having a morphological impairment. Individuals with 
morphological impairments typically have left frontal damage which has 
repeatedly been shown to have increased difficulty inflecting verbs as 
compared to nouns. A selective impairment of verb morphology has been 
linked to individuals with agrammatic Broca’s aphasia presenting with non-
fluent, highly reduced speech lacking grammatical features, and a decrease 
in the production of verbs and nouns (Ballard & Thompson, 1999; Edmonds & 
Babb, 2011; Edmonds, Nadeau, & Kiran, 2009; Martin, Fink, & Laine, 2004;  
Nickels, 2002; Raymer, & Ellsworth, 2002;Cameron, Wambaugh & 
Mauszycki, 2010;Wambaugh & Ferguson, 2007; Peach & Reuter, 2010;  
Wilkinson, Bryan, Lock, & Sage, 2010; Lee, Kaye,& Cherney, 2009; Basso, 
2010). An example of morphological deficits from this study would be the 
“man walk (omitted ‘ed’) on street”. Treatments for morphological deficits in 
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agrammatic Broca’s aphasia have focused on verb infection tasks, subject-
verb agreement, tense marking, and the use of subordinate conjunctions 
(Dickey, Milman, & Thompson, 2008; Shapiro, Shelton, & Caramazza, 2000). 
Another area of deficit for this population involves difficulty retrieving words.  
Lexical Retrieval Deficits  
Another linguistic factor that contributes to fluent language production 
is the lexical retrieval of words. Deficits in lexical retrieval almost always 
accompany some type of language disturbance associated with brain damage 
(Friedmann, Biran, & Dotan, 2013).  Individuals with agrammatic Broca’s 
aphasia demonstrate deficits that are semantic in nature with difficulty 
accessing the meaning, difficulty in accessing and producing the correct 
forms of words. Furthermore, there may be substitution errors or paraphasias 
or deficits with morphological forms of words. Additionally, individuals with 
agrammatic Broca’s aphasia may demonstrate difficulty with grammatical 
classes of regular and irregular verbs and grammatical suffixes. Similarly, 
there may be difficulty with abstract words versus concrete word retrieval. 
Treatments for lexical retrieval deficits has ranged from semantic feature 
analyses, confrontational naming tasks, imagery and frequency of words, and 
action verb naming (Peach & Wong, 2004, Thompson et al., 2013.; Youmans, 
Youmans, & Hancock, 2011). Also, the grammatical categories such as 
nouns, verbs, adjectives or prepositions may increase lexical retrieval 
difficulty in individuals with aphasia. Furthermore, fluent language production 
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may be limited by poor grammatical structure of language during sentence 
production and conversation.  
Syntactic Deficits  
Syntactic disorders are another linguistic factor that compromises 
fluency in individuals with aphasia.  Syntax is the study of the principles and 
processes by which sentences are constructed in a particular language. 
Deficits in syntax involve word order. In this study, P2 produced the phrase 
“brush… teeth….men (The man was brushing his teeth) which illustrates 
difficulty with number, tense, and word order.”   Individuals with agrammatic 
aphasia often have difficulty producing subject-verb-object sentences; which 
are the most basic of syntactic forms. Additionally, the sentence type, the 
number of clauses, and the verb tense can all play a role in the syntax of 
individuals with aphasia. Agrammatic Broca’s aphasia was considered largely 
a problem of sentence production that reflects an absence of grammatical 
structure (Jacobs & Thompson, 2000; Thompson, Shapiro, Kiran, & Sobecks, 
2003). In addition to sentence production deficits and word retrieval deficits, 
individuals with agrammatic Broca’s aphasia may have difficulty 
comprehending sentences that are reversible in which two nouns are equally 
probable candidates for the role of the agent.  The agent is the noun phrase 
(NP) in the sentence (Jacobs & Thompson, 2000). Furthermore, individuals 
with agrammatic Broca’s aphasia may have deficits in sentence production 
and comprehension when the traditional noun phrase has been moved out of 
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the canonical subject-verb-object position (e.g. Zack was chased by Quinn). 
Discourse and conversation are more functional aspects of language that 
require all areas of language: including sentence production, syntax, 
morphology, lexical retrieval and comprehension to be intact.  
Discourse/Conversation Deficits 
Another linguistic factor that can affect fluent language production is 
the ability to produce discourse or conversation. There are four primary 
domains of discourse: expository, narrative, persuasion, and description. 
Discourse requires the comprehension of individual words and sentences as 
well as the integration across sentence representation to form a coherent 
understanding of discourse. Individuals with agrammatic Broca’s aphasia 
present difficulty both socially and linguistically processing discourse and 
conversation due to the nature of the interaction (Cameron, Wambaugh, 
Mauszycki, 2010; Wambaugh & Ferguson, 2007; Peach & Reuter, 2010; 
Wilkinson, Bryan, Lock, & Sage, 2010; Lee, Kaye, & Cherney, 2009; Basso, 
2010). 
Evidence-Based Treatment Options for agrammatic Broca’s aphasia 
Many studies have shown that speech-language treatment has a 
significant and in some cases quite large treatment effects in persons with 
agrammatic Broca’s aphasia (Edmonds, Nadeau, & Kiran, 2009).  Such 
studies have involved between-group, and/or within-group comparisons as 
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well as studies that used single- case study controlled experimental designs. 
The primary question of research in aphasia has been to determine the 
therapeutic value of behavioral intervention in the recovery of language due to 
acquired brain damage. Furthermore, the primary question of interest was 
whether aphasia treatment improves language ability. Studies have been 
influenced by treatments grounded in the psycholinguistic, cognitive theories, 
and neuropsychological theories, and other models of language for oral and 
written naming (Martin, Fink, & Laine, 2004; Kiran & Thompson, 2003; 
Beeson & Hillis, 2001; Raymer & Rothi, 2001). Additionally, other studies 
have examined the treatment effects of naming, word meaning, sentence 
production, and comprehension in aphasia (Boyle, 2004; Thompson & 
Shapiro, 2005). In the current study, a linguistic approach with an impairment 
based treatment such as (VNeST) and a functional approach such as (Script) 
are being compared.  
There are various treatment options for agrammatic Broca’s aphasia. 
(Youmans, Youmans, & Hancock, 2011; Youmans, Holland, Munoz, & 
Bourgeois, 2005; Thompson, Shapiro, Kiran & Sobecks, 2003; Jacobs & 
Thompson, 2000; Friedmann & Shapiro, 2003; Ballard & Thompson, 1999). 
Such studies have addressed the training at both the word level and sentence 
level. These studies have focused in using treatment options such as a 
Semantic Feature Analysis (Peach & Wong, 2004), Treatment of Underlying 
Forms (Thompson & Shapiro, 2005), and training of verbs (Thompson et al., 
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2013). Thompson et al. (2003) and Jacobs and Thompson (2000) examined 
whether the training of syntactically complex sentences would result in the 
generalization to less complex sentences in individuals with agrammatic 
Broca’s aphasia. Additionally, individuals with agrammatic Broca’s aphasia 
had difficulty comprehending sentences in which the noun phrases have been 
moved out of the canonical (S-V-O) position as in passives or object clauses. 
The training of syntactically complex sentences involves participants whom 
will navigate through a series of steps that emphasize the verb and verb 
argument structure as well as the ability to derive target sentences. In the 
results, Jacobs and Thompson (2000) and Thompson et al. (2003) explained 
that sentence production and comprehension are based on the linguistic 
complexity. Furthermore, the comprehension training resulted in the 
generalization to production; whereas, production treatment has little effect on 
comprehension ability.  Additionally, the comprehension treatment of trained 
sentences was superior to the production treatment in facilitating 
generalization in individuals with agrammatic Broca’s aphasia.  One limitation 
of this study was that the participants were not expected to produce the oral 
reading of written sentences stimuli during comprehension training and so it is 
possible that production improved because the comprehension treatment 
contained a production component (Jacobs & Thompson, 2000). Thompson 
et al. (2003) found that comprehension as well as production improved during 
treatment. Furthermore, the comprehension treatment of trained sentences 
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was superior to the production treatment in facilitating generalization in 
individuals with agrammatic Broca’s aphasia.  Other types of therapy for 
chronic aphasia focus on using scripts to ensure participation in a full range of 
vocational, recreational, and social activities. 
Aphasic Severity and Chronicity 
Individuals with agrammatic Broca’s aphasia benefit from a variety of 
different treatments, even months and years beyond the time of onset. 
Recently, emphasis has been put on the need for intensive aphasia treatment 
to make the long-term neuroplastic changes associated with recovery and 
rehabilitation following a stroke (Cherney, 2010). Yet, such treatment is not 
always available. In fact, patients may be eligible for only a limited number of 
treatment sessions following their acute hospitalization, and the costs of 
communication treatment delivered to patients with chronic aphasia (beyond 
12 months after onset) are not often reimbursable (Cherney, Patterson & 
Raymer (2011). There is a need to identify treatments that are appropriate 
and efficacious even when provided at low intensity, and easily administered 
to individuals with chronic aphasia. On average for treatment intensity, 24-85 
hours of treatment were offered as helpful for chronic non-fluent aphasics 
(Cherney, Patterson, Raymer, Frymark, & Schooling, 2008). In the current 
study, both participants received both treatments for a total of 18 weeks and 
two sessions per week which were an hour long each.  
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Theoretical Framework 
Impairment Specific Approach vs. Social-Functional Approach  
  Two major approaches to aphasia treatment have emerged: One 
approach was called an impairment specific approach to aphasia treatment; 
the other approach was called the social functional approach.  The 
impairment specific approach addresses specific linguistic factors such as 
naming, word retrieval, verb production, morphology, or sentence production 
during treatment (Raymer et al., 2008; Peach & Wong, 2004; Thompson & 
Shapiro, 2005; Thompson et al., 2013; Youmans, Youmans, & Hancock, 
2011). The impairment specific approach focuses on the impaired language 
structures or processes and provides direct intervention to improve the 
weaker areas. The assumption of the impairment specific approach is that 
treatment of specific aspects of language (e.g. naming) will have broad, 
spreading effects across language areas and broader communication 
systems. In the current study, the results of the baseline in-depth 
assessments helped identify areas of language breakdown and language 
intervention targets that will bolster the entire language system using a 
treatment such as VNeST.  
The second approach is called the social or functional approach. A 
social functional approach is based on the individual’s communication 
environment. Under the social functional approach, treatment goals and 
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procedures are determined by shared decision making where functional 
language tasks such as conversational discourse are explored. Treatment 
focuses on functional language tasks such as narratives, sentence 
production, and conversational discourse (Kagan 1998, Cruice, Worrall, 
Hickson, & Murison 2003, Kagan et al, 2008). 
Bottom-Up Approach vs. Top-Down Approach  
The impairment specific approach to aphasia has been described as a 
“bottom-up approach” (Basso, 2003), in which language components are 
considered the building blocks of communicative abilities. Bottom-Up 
Approach has focused on the idea that the weaker areas of language (i.e. 
word retrieval) are targeted first and this helps to strengthen residual 
language capabilities (Basso, 2003).   
Social functional approaches have been described as “top-down”. The 
social functional approach (Basso, 2003) focuses on the social participation 
for everyday life activities. Script Therapy is based on a social functional 
method for communication. A simple comparison of a “bottom-up” to a “top-
down approach” might lead to the idea that both approaches will help identify 
which treatment is best for specific clients to achieve certain outcomes.  For 
the purposes of this study, both an impairment specific approach such as 
Verb Network Strengthening Treatment (VNeST) and a functional 
communication approach such as Script Therapy will be analyzed to see what 
 
 
16 
 
method of treatment causes change to the pre-to-post outcome measures of 
rate of speech, SVO production, and error rate.   
 Script Therapy  
Script therapy was chosen as it is a functional approach to aphasia 
therapy that can facilitate participation in personally relevant conversational 
activities. Previous studies have utilized group treatment and training of the 
communication partner to help improve evidence based practice in individuals 
with aphasia (Elman & Bernstein- Ellis, 1999; Kagan, Black, Duchan, 
Simmons-Mackie, & Square, 2001). Additionally, treatment studies have also 
utilized computerized technology to improve language production and 
comprehension in aphasia. 
Script training is a functional approach to aphasia therapy that can 
facilitate participation in personally relevant activities (Cherney, Halper, 
Holland, & Cole, 2008; Youmans, Youmans, & Hancock; 2011; Bilda, 2011; 
Youmans, Holland, Munoz, & Bourgeois, 2005; Cherney, Halper, & Kaye, 
2011). Scripts guide and facilitate the identification of participant’s 
conversations and actions involved in social situations. Furthermore, Scripts 
can provide knowledge including the understanding, remembering, and 
recalling of the temporal organization of events in a routine activity. 
Youmans et al. (2005) conducted a study on two individuals with Broca’s 
aphasia who intensively practiced speaking Scripts as monologues and 
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conversational contexts. In this study, Scripts were trained one phrase at a 
time.  A cueing hierarchy was used to train new material: phrase repetition, 
choral reading of passages and then independent production (Youmans et al. 
2005). Once a script was mastered, generalization training was implemented. 
During the generalization phase, monologue scripts were practiced in 
conversational form with novel conversational partners. Both participants were 
assessed on their ability to produce automatic speech production as measured 
by relatively errorless speaking, increased speaking rate, and consistency in 
using the scripts.  Both participants were measured using the percentage of 
scripts correct, error rate, and the speaking rate. Percentage of script words 
was the number of script words produced divided by the total number of words 
in the script. Circumlocutions and substitutions were excluded from the total 
number of words. The error rate was defined as non-communicative words or 
phrase repetitions, fillers, pauses of 3 seconds or more, and unrecognizable 
utterances. Speaking rate was the duration of each script and a word per 
minute rate was calculated. The results of this study suggest that script training 
was an effective treatment with individuals with non-fluent aphasia (Youmans 
et al. 2005). Additionally, both participants produced an increase in the 
percentage script correct scores and an increase in speaking rate.  
Recently, the method of script training has changed from a typed script 
to a computerized program for script production (Bilda, 2011; Cherney, Halper, 
Holland, & Cole, 2008; Cherney, Halper, & Kaye, 2011; Cherney, Halper, 
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Holland, Lee, Babbitt, & Cole, 2007).  This computerized treatment is a cost 
effective medium for therapy and emphasizes the development of 
conversational skills in everyday life.  The computerized script therapy program 
is called AphasiaScripts (Cherney et al., 2008). AphasiaScripts is a software 
program using an animated agent that serves as a virtual therapist for Script 
training. Additionally, the visual therapist is programmed to produce natural 
speech with correct movements of the articulators for speech. AphasiaScripts 
provides repeated opportunities for the client to practice individualized 
conversations that have been pre-recorded. Script training has multiple types 
of cues including oral motor cues, written words, and choral speaking of the 
virtual therapist.  Computerized script training has three phases including: the 
client will listen silently to the entire script. Next, each sentence that is part of 
the client’s conversational turn is practiced and the entire conversation is 
practiced repeatedly in turn taking with the virtual therapist.    
 The treatment protocol of script therapy involves the development and 
automatization of personal scripts and then script practice (Cherney et al. 
2008). The initial 4 weeks of therapy, are devoted to the development of the 
conversational scripts by a speech-language pathologist in partnership with the 
participant with aphasia. The participant will identify and prioritize three script 
scenarios (Cherney et al. 2008; Cherney et al. 2007; Cherney et al. 2011). 
Script practice involves baseline measures taken to ensure script reliability. 
Additionally, the speech-language pathologist will instruct the client on the use 
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of scripts at home for a minimum of 30 minutes per day (Cherney et al. 2008; 
Cherney et al. 2007; Cherney et al. 2011). The client is responsible for 
progressively removing the cues and the client makes weekly visits to the 
speech language pathologist to ensure script practice is ongoing.  
 Quantitatively, individuals with aphasia using script therapy in numerous 
studies were measured based on content including the number and percent of 
script related words, grammatical complexity including the number of 
morphemes, nouns, verbs, and modifiers as well as rate (Cherney et al., 2008; 
Cherney et al., 2007; Cherney, et al, 2011; Bilda, 2011). In previous studies, 
the use of Script therapy with Broca’s aphasia has led to increased content, 
grammatical productivity, and rate of production (Cherney et al., 2008; Cherney 
et al., 2007; Cherney, et al, 2011; Bilda, 2011). Additionally, the individuals with 
agrammatic Broca’s aphasia used the scripts to generalize to more social 
communication exchanges. Furthermore, other types of therapy programs 
have been found to be beneficial for agrammatic Broca’s aphasia including 
Verb Network Strengthening Treatment (VNeST). 
Verb Network Strengthening Treatment (VNeST) 
In recent years, verb-centered treatment programs have emerged to 
address lexical retrieval deficits in sentence production (Edmonds & Babb, 
2011). Such verb-centered programs have included sentence completion, 
cueing hierarchies, picture naming, and semantic feature analysis for verbs and 
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retrieving verbs. These previous treatment programs emphasize improvements 
in the retrieval of trained verbs which can result in improved sentence 
production with those verbs. However, increased lexical production does not 
necessarily result in improved sentence production. Additionally, generalization 
of these verb-centered programs has led to mixed findings. 
Verb Network Strengthening Treatment (VNeST) is defined as an 
impairment specific semantic treatment that aims to improve lexical retrieval of 
content words in sentence context by promoting systematic retrieval of verbs 
and their thematic roles (Edmonds, Nadeau, & Kiran, 2009). Individuals with 
agrammatic Broca’s aphasia may benefit from the use of predicative 
components of the semantic representations of concepts. Predicative 
components are features of nouns that add meaning (Edmonds et al., 2009). 
For instance, running, leaping, barking, and whining can be predicative 
components of a dog concept representation (Edmonds et al., 2009). VNeST 
may also increase the semantic representations of the verbs. The basic task of 
VNeST is to generate agent and patient pairs to a target verb (Edmonds et al., 
2009). For example, these agent and patient pairs could be ‘chef’ to ‘sugar’ or 
‘carpenter’ to ‘lumber’. Furthermore, the intent of VNeST is to strengthen the 
connections between the verbs and their thematic roles. Edmonds et al. (2009) 
conducted a study on four aphasic individuals: two individuals had transcortical 
motor aphasia and the other two participants had conduction aphasia.  All four 
individuals were evaluated during a connected speech task using a picture 
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description and Cinderella narrative task to measure their discourse abilities. A 
Systematic Analysis of Language Transcripts (SALT) (Miller & Iglesias, 2012) 
was used to measure each participant’s number of utterances and mean length 
of utterances. A complete utterance was considered one that used an agent, 
verb, and object. Before treatment, participants showed deficits in producing 
complete utterances from 50% to 62%. Additionally, the number of phonemic 
and semantic errors were identified and verb naming accuracy varied across 
participants before treatment. Sentence elicitation pictures were developed for 
baseline and treatment probes and a control task of adjective retrieval was also 
used during this study. The treatment stimuli consisted of 10 trained verbs and 
6-8 cards for each verb containing 3-4 agents and 3-4 patients related to each 
verb (Edmonds et al., 2009). Additionally, questions of who, what, where, when, 
and why and 12 sentences were used that contain the inappropriate agent, 
inappropriate patient, and thematic reversal. VNeST was administered twice 
per week for 2-hour sessions. Participants performed the treatment steps that 
aimed to strengthen the semantic meaning of the target verb and to promote 
stronger associations between the verb, related agents, and patients.  
 In the results, the correct production of the agent, verb, and patient in 
the picture description depicting trained actions increased for all participants 
except one participant with conduction aphasia.  All participants achieved 
generalization of untrained verbs. Additionally, all participants were able to 
generalize both treated and untreated verbs. Additionally, all participants 
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showed an increase in single noun retrieval and three of the four participants 
improved on agent-verb-patient retrieval in sentences. Three of the four 
participants showed improvement in the ability to produce utterances 
containing a relevant subject, verb, and object with an increase in utterances 
overall. Participant 4 had conduction aphasia and did not show improvements 
in connected speech on any measure. Overall, VNeST does generalize to 
nouns and verb retrieval in sentence production.  
 Edmonds and Babb (2011) examined the effects of VNeST with two 
participants with more moderately severe Broca’s aphasia. The treatment 
protocol was the same as in Edmonds et al. (2009) as the participants were 
rated on their single word naming of objects and actions, evaluated on 
sentence production, evaluated on the production of correct information units 
in discourse, and the ratings of functional communication as based on the 
Communicate Effectiveness Questionnaire (CETI; Lomas et al., 1989).  In the 
results, participant 1 exhibited a small increase in noun retrieval; whereas, 
participant 2 resulted in a significant increase in retrieval of nouns. Additionally, 
both participants exhibited an increase in words from pre-to-post treatment in 
their production of correct information units and their use of neologisms 
decreased. On the CETI scale, both participants demonstrated a significant 
increase in ratings of functional communication (Edmonds & Babb, 2011). A 
few limitations of this study included the necessity to include the relationship 
between verbs and their thematic roles, treatment intensity and duration is 
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another limitation as well as the participant factors, generalizability outcomes, 
cognitive linguistic factors, and access to the communication partners.  
Problem 
There is limited previous research on individuals with agrammatic 
Broca’s aphasia and their ability to consistently produce sentences.  In previous 
research, there were many approaches to treatment with individual with 
agrammatic Broca’s aphasia, but few have been cost effective and addressed 
treatment of language skills in realistic contexts. Additional factors that may 
contribute to the variability with this agrammatic Broca’s population are length 
of time between onset of neurological event and the length of time of treatment. 
For some people, aphasia will be temporary, resolving in the first few days or 
even hours after their stroke or brain injury.  Others will have a long recovery 
of months or years. Some people may improve to a degree in the first few 
months, but will still live with a severe aphasia that affects their ability to 
communicate for the rest of their lives. It is rare for people to make no 
improvement at all. 
The typical pattern of recovery is for aphasia to be at its worst initially, 
with spontaneous recovery occurring most rapidly in the first few days, weeks 
and even months. Spontaneous recovery is a term used to describe the 
improvement that happens as the brain heals from a stroke or brain injury. 
Traditionally, experts have advised people that there was a finite period of time 
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during which the brain would heal, after which improvement was no longer 
likely. While there is disagreement over the length of time, spontaneous 
recovery may occur within the first year. There has long been general 
agreement that there was a “window of opportunity” for improvement to be 
capitalized on by therapy, after which people improved mainly by adapting to 
their aphasia (Smania et al.,2010).  Few studies have used these two 
treatments: Script Therapy and Verb Network Strengthening Treatment with 
individuals with aphasia. 
Aim of the Study 
 The aim of this study was to determine the efficacy of the two treatment 
approaches: Script and VNeST for the agrammatic broca’s aphasic population.  
Significance of the Study 
In the current healthcare situation, clinicians are expected to make 
informed decisions in the choice of treatment that yields results at a lower or 
minimal cost. Therefore, it is important from an evidence based practice 
perspective to explore further treatment options. For the purposes of this 
research, what remains unclear is the effectiveness of these two treatments on 
language outcomes at the word, sentence and discourse level measures in 
individuals with agrammatic Broca’s aphasia. The comparison of the two 
treatments in this study has not been previously researched with individuals 
with agrammatic Broca’s aphasia. In examining the feasibility of combining 
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treatment approaches for individuals with agrammatic Broca’s aphasia, it is 
important to use of a single subject multiple-baseline alternating treatment 
across participants’ design that allows for conclusions about cause and effect, 
interval validity, and feasibility. 
Research Questions/Hypotheses 
1.) RQ1. Does the combination of Script and VNeST interventions 
improve language outcomes in individuals with chronic agrammatic 
Broca’s aphasia during standardized assessment measures? 
    H1a. Participants will increase language skills including naming, 
comprehension, narrative production and cognitive skill areas from pre-
treatment to post-treatment. 
2.) RQ2. Do the participants show gains in word level, sentence level, 
and discourse level measures obtained from baseline to maintenance 
phases? 
H2a. Participants will show gains in rate of speech, SVO production, 
and decrease error rates obtained from language samples at baseline 
through maintenance phases. 
3.) RQ3. What are the relative effects across interventions on word, 
sentence, and discourse level measures obtained from language 
samples? 
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H3. Large effect sizes will be found on word, sentence, and discourse 
level measures across interventions. 
3a.) RQ3a. What are the relative effects for each participant on 
word, sentence, and discourse level measures across interventions? 
H3a Large effect sizes will be found on word, sentence, and 
discourse level measures for each intervention per participant.   
4.) RQ4. How does Script compare to VNeST intervention for improving 
language outcomes in individuals with chronic agrammatic Broca’s 
aphasia? 
   H4a. VneST will be more efficient in improving language outcomes for 
the chronic agrammatic population. 
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Chapter III 
 
METHOD 
 
Study Design 
 This study used a single subject multiple baseline alternating treatment 
across participants’ design. This study design included four phases: baseline, 
treatments 1 or 2 and then reversed, post treatment and a 4- week 
maintenance phase to reassess probe tasks. Two participants diagnosed with 
agrammatic Broca’s aphasia by the primary investigator during inclusion testing 
participated in the study. Both participants entered the baseline treatment and 
the treatments were counterbalanced against one another. Weekly randomized 
probe tasks (video, picture description/sequencing, and procedural narratives) 
were administered during the second session of each week during the study. 
Additionally, a picture description probe task was administered at baseline, 
between treatments, and post treatment to control for learning effects. 
 Single Subject Designs 
 Due to the limited number of individuals with aphasia and the 
heterogeneity of the disorder, single subject designs are often the nature of 
research in this area. Most treatment studies in aphasia have less than five 
participants. Use of single subject multiple baseline alternating treatment 
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designs allow for the careful selection of study participants for the specific 
nature of their language impairment, precisely describing the components of 
treatment as well as the outcome measures, and carefully gathering reliability 
data. Furthermore, through the use of single subject designs, researchers 
have discovered treatments that are effective for patients with certain types of 
language impairments (Thompson, 2006, Kiran & Thompson,2003; Edmonds 
et al., 2009; Martin et al., 2004, Beeson & Robey, 2006). 
 Knowing the effects of specific types of treatment for patients with 
certain language impairments as well as understanding the extent to which 
these treatments result in generalized language use is important particularly 
in the current health care climate, which imposes limitations on the treatment 
that can be provided. Treatment outcome research measures changes during 
or after the treatment process and addresses a variety of questions including 
cost of treatment, quality of care, and achievement of functional change in the 
client (Olswang, 1993). The outcome or benefits of treatments are 
documented as “real world” conditions. Demands for data that show 
significant, cost-effective changes in client behavior following interventions 
have resulted in an increase in outcome research. Single subject designs are 
less focused on exploring how treatment alters behavior but rather the 
treatment is associated with important changes in a client’s life that 
contributes to ecological validity (Schwartz, 2010, Olswang, 1993, Robey, 
2004). Treatment outcome research yields meaningful effects when the 
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intervention comes packed into a less costly program (Fey & Finestack, 
2009). Additionally, treatment outcome research can help increase external 
validity and generalizability to real-world clinical applications and identity 
specific treatment benefits for smaller populations (Robey, 2004).   
Feasibility of Single Subject Multiple Baseline Designs. The 
principle purpose of feasibility research has less to do with measuring 
treatment outcomes than with evaluating the clinical viability of untested 
interventions. Publications of feasibility research is pivotal to the development 
of a strong research based that helps to support evidence based practice. 
Additionally, publications of these works can encourage discussions across 
research including advances in interventions, validating outcome measures, 
and strengthening research designs. Effectiveness studies or treatment 
outcome research can evaluate the effects of efficacious treatments across 
broader, more typical populations and under broader, more typical clinical 
conditions (Fey & Finestack, 2009; Schwartz, 2010; Olswang, 1993).  
The feasibility of multiple baseline designs incudes that a withdrawal of 
an effective treatment is not required to demonstrate the functional 
relationship between independent variables and dependent variables. 
Furthermore, the generalization of the behavior change is monitored through 
the design. Replication of multiple baseline designs can provide evidence that 
the data paths change in predictable manners from baseline to intervention 
through maintenance phases.  
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Effect sizes and Single Subject Designs. An effect size is computed 
for each empirical study investigating a specific treatment and then is 
averaged across studies to provide a summary statistic on the interventions 
effectiveness (Rogers & Graham, 2008). Single subject designs can be used 
to test whether a treatment is responsible for observed changes in 
performance. Additionally, Rogers and Graham (2008) discuss the major 
threats to interval validity are controlled by within and between subjects’ 
comparisons, and external validity is enhanced through systematic 
replication. In single subject designs studies, participants serve as his or her 
own controls with performance prior to as well as during and/or after 
intervention which is repeatedly measured to establish performance patterns 
across baseline through maintenance phases which was used in this study.  
Experimental control. One method for establishing experimental 
control involves the introduction and withdraw of treatment.  A multiple 
baseline design involves implementing a stable baseline of performance 
followed by treatment to determine changes in the dependent variable, 
followed by the withdrawal of treatment to determine whether performance 
returns to baseline levels, followed by treatment again. Multiple baseline 
designs involve the staggering of both within and between subject 
comparisons. In multiple baseline studies, researchers establish a baseline 
pattern of performance for each participant, then treatment is implemented 
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with one participant to determine whether it influences the performance in a 
predictable fashion (Rogers & Graham, 2008).  
To demonstrate interval validity in single subject designs, performance 
within the same participants is compared before and during treatment 
implementation (Koutsoftas, Harmon, & Gray, 2009). In a multiple baseline 
across participants’ design, experimental control is demonstrated when 
performance changes for the participants who begin different treatments 
(McReynolds & Thompson, 1986). With regards to this study, both the weekly 
probe tasks and the mid-treatment picture description tasks were 
administered for further demonstration of experimental control.  
Institutional Review Board 
 Completed applications were submitted to Hackensack University 
Medical Center and LaSalle University Institutional Review Boards (IRB). 
Approvals from both Institutions were received (Appendix A & B). After 
obtaining IRB approvals, participant recruitment started. Hackensack 
University Medical Center and Seton Hall University IRB approval # 
Pro00006239 (continuation approved on 4/27/17) and LaSalle University IRB 
approval # 15-03-009.3-17-RC (continuation approved on 3/27/17).  
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Timeline for Study 
 
  Figure 1. Timeline for study over the course of 26 weeks 
The length of the study was 26 weeks long. After signed consents, the 
first two weeks were devoted to pre-treatment testing and baseline probe 
measures. After the baseline probes measures were administered, both 
participants were randomly selected through a coin toss and administered 
alternate treatments. P1 received Script therapy and then VNeST. P2 
received VNeST then Script. After the first nine weeks, the treatments were 
stopped and both participants took a two-week break from treatment. Once 
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the break was over, the participants were re-evaluated using the mid-
treatment probe and the second alternate treatment was implemented. After 
18 weeks, the final probes were administered and the four-week maintenance 
probe measures were assessed. 
Method of Recruitment 
 All recruitment efforts respected participants’ right to privacy and 
confidentiality in the research site. Speech-language pathologist who cover 
the LaSalle University Clinics approached the potential participants and asked 
if they were interested to participate in the study. Once the participant agreed 
to the study, the principal investigator explained the details of the study. The 
patient must be competent of understanding the facts about the research and 
were able makes decisions. The primary investigator delivered all the 
necessary information about the study, including the goals, benefits, and 
potential risks.  
 The participants who agreed to participate in the study received a 
consent form. The consent forms stated the researcher’s affiliations with 
Seton Hall, Hackensack, and LaSalle University, the purpose of the research, 
expected study duration, rights of the patients, benefits and risks and the 
description of the procedure. Both participants signed the informed consent 
form.  
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Participants  
Sampling Procedure  
 Two participants were recruited from the LaSalle University Speech-
Language-Hearing-Community Clinic in Philadelphia, PA. This study used a 
convenience-sampling technique where participants were selected based on 
their accessibility to the research and type of aphasia.  
Inclusion Criteria 
The participants met several inclusion criteria including (a) diagnosis of 
aphasia quotient of <50 on the Western Aphasia Battery (WAB-R; 
Kertesz,1982), (b) monolingual English speaking, (c) right handiness prior to 
stroke, (d) considerable verb retrieval deficits as diagnosed from the 
Northwestern Assessment of Verb Production Battery (NAVS; Thompson, 
2002), (e) negative history of diagnosed learning disorder, and (f) no worse 
than a composite score of a mild deficit on the Cognitive Linguistic Quick Test 
(CLQT; Helm-Estabrooks, 2001) (g) Both participants were in the intended 
age ranges of 25-65 years old. Additionally, the Apraxia Battery for Adults 2nd 
Edition (ABA-2; Dabul, 2000) was administered to determine the presence or 
absence of speech, oral or limb apraxia. All participants earned a high school 
diploma or better. Aided visual acuity was judged within normal limits. Hearing 
was unaided and judged as within normal limits. Participants were not to be 
enrolled in any other speech and language therapy at the time of the baseline 
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testing phase of the study. Both participants demonstrated adequate reading 
of single words.  
Exclusion Criteria 
            Three exclusions for this study included participants with greater than 
a mild cognitive impairment including participants with a history of previous 
learning disability, participants already enrolled in treatment, and participants 
with other types of aphasia. An additional participant was evaluated and 
excluded due to the type of aphasia.  
Participant Demographics 
P1 was a 32- year-old right-handed woman with 16 years of education. 
In 2007, P1 was diagnosed with a craniopharyngioma and received a partial 
resection. At that time, there were no reported problems with speech and 
language due to the tumor. Twenty months before beginning the study, P1 
had a left hemispheric stroke. According to CT scans, she sustained a 
massive left middle cerebral artery stroke (MCA) extending from the 
striatocapsular territory extending to the frontal lobe. Subsequent to her 
stroke, she underwent a craniotomy to relieve pressure. Prior to her stroke, 
P1 was a college student finishing all but one class as a Criminal Justice 
Major. Immediately after her stroke, P1 received speech and language 
therapy at a rehabilitation hospital, but discontinued it eight months prior to 
participating in the current study. Additionally, she had a history of seizures 
 
 
36 
 
after the stroke with which she takes the medication Gabapentin. P1 did not 
report any seizure activity six months prior to the stroke, during the study or 
after the maintenance period.  P1 passed the hearing screening prior to the 
study at 30 db. 
 P2 was a 46-year-old right-handed male with 16 years of an 
education. Twenty- six months prior to the study, he had a large severe MCA 
with mass effect from the parenchymal edema the invoking the 
temporoparietal region as noted from his CT scan. P2 passed the hearing 
screening at 35 db. Prior to his stroke, P2 worked as a business manager. P2 
received speech therapy for approximately 15 months after his stroke, but he 
had discontinued this therapy six months prior to enrollment in this study. This 
participant had a medical history of high blood pressure and depression after 
the CVA.   
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Table 1.  
Participant Demographic Information  
Participant Age & 
Gender 
Years of 
Education 
Handedness 
Of Subjects 
Years 
since 
Onset 
Site of 
Lesion 
Occupation 
Prior to 
Illness 
P1 32, 
Female 
16 Right 20 
months 
MCA Student 
P2 46, 
Male 
16 Right 26 
months 
MCA Manager 
 
 
Procedures 
Prior to the initiation of the study, approval for all procedures was 
granted by the institutional review board associated with the primary 
investigator’s affiliated universities (LaSalle University and Hackensack 
University Medical Center). The following section outlines: a) Language 
testing to determine eligibility, b.) Post-treatment testing, c.) Procedures to 
assess pre-to-post language measures. 
Pre-treatment Language Testing 
All participants underwent initial eligibility testing including: The 
Western Aphasia Battery-Revised (WAB-R; Kertez, 2006), The Cognitive 
Linguistic Quick Test (CLQT; Helm-estabrooks, 2001), the Apraxia Battery for 
Adults (ABA; Dabul, 2000), the Boston Naming Test (BNT; Kaplan, 
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Goodglass and Weintraub, 1983), The Northwestern Verb Production 
Battery/The Northwestern Assessment of Verbs and Sentences (NAVS; 
Thompson, 2002), and the use of the elicitation materials from Nicholas and 
Brookshire, 1993). Additionally, all pre- and post-treatment testing was 
conducted by the primary investigator.  
Table 2.  
 
Pre-Treatment Assessment Scores 
 
 WAB-R BNT 
N =60 
NAVS 
N=22 
CIUS CLQT ABA-2 
P1 46.5 31 11 14 183 
Attention, 
160 Memory, 
31 Executive 
Functions, 
15 
Language, 
(Severe) ,91 
Visuospatial 
Skills 
Mild 
P2 42.5 30 8 10 191 
Attention,181 
Memory,24 
Executive 
Functions   
11 
Language- 
(Severe), 83  
Visuospatial 
skills  
 
WNL 
 
 
Testing Materials (Reliability and Validity) 
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 Western Aphasia Battery-Revised (WAB-R, Kertesz, 2006). All 
participants’ aphasia profiles were obtained by administering the WAB-R 
(Kertesz, 2006). This standardized test was used to obtain an aphasia 
quotient, which is a composite score that includes picture description, auditory 
comprehension, repetition, spontaneous speech, and naming tasks. 
Participants were identified as having agrammatic aphasia which includes 
difficulty with language production characterized by short utterance lengths 
with one to two words, relatively adequate comprehension, poor repetition, 
reduced fluency, and decreased naming.  
Reliability and Validity of Western Aphasia Battery-Revised. The 
WAB-R was standardized on 4 populations:150 patients of all etiologies 
including 365 aphasics and 161 total controls. Criterion Validity indicated the 
extent to which a test may be used to estimate an individual’s standing in 
respect to their disability with a Pearson Correlation Coefficient score of (.96), 
an internal consistency score of (.91) indicating a high internal 
consistency. An intra-rater reliability correlations of 10 tests administered 
indicated that correlations were obtained for each subsection and judged as 
high. Interrater reliability (range .98 to.99) correlations were consistent over 8 
raters. For test-retest reliability, the WAB-R yielded a score of (.99). A 
criterion for differentiating aphasics from controls is validated-high construct 
validity, test-retest reliability, intrarater, and interrater reliability was shown.  
 
 
40 
 
Boston Naming Test Reliability and Validity (BNT; Kaplan, 
Goodglass & Weintraub, 1983). This test consisted of a 60- item 
confrontation naming test.  All participants were administered the BNT to rule 
out confrontation naming deficits. The participants in the study scored less 
than 30 on the Boston Naming Test. An interjudge reliability on 12 out of 60 
BNTS scored from 85.9%-95.2%. The interjudge reliability score was (.98).  
Intercorrelation scores were (.81) for the BNT.  
Cognitive-Linguistic Quick Test (CLQT, Helm-Estabrooks, 2001). 
This assessment assessed five cognitive domains: attention, memory, 
language, executive functions, and visuospatial skills. The CLQT version 
provides a standardized scoring system that permits analysis of language, 
visuospatial planning skills, and conceptualization of time. The CLQT was 
normed on 171 non-clinical cases and 38 clinical cases, including TBI.  
Reliability and Validity for the CLQT. For test-retest reliability, the 
CLQT was administered to 46 examinees on 2 separate occasions. The test-
retest coefficients ranged from 0.03 and 0.81 for each subtest and from 0.61 
to 0.90 for cognitive domains. Interscorer agreement was (.86) among two 
scorers. Test content validity was rated as (.74) for found for the Composite 
severity rating and each subtest.  
Northwestern Assessment of Verbs and Sentences (NAVS, 
Thompson, 2002). The NAVS was designed to examine comprehension and 
production of action verbs, production of verb argument structure in sentence 
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contexts, and the comprehension and production of canonical and non-
canonical sentences in individuals with language disorders resulting from 
neurological disease. There were five subtests including the Verb Naming test 
(VNT), the Verb Comprehension Test (VCT), the Argument Structure 
Production Test (ASPT), the Sentence Production Priming Test (SPPT), and 
the Sentence Comprehension Test (SCT). A total of 103 individuals with 
aphasia participated in standardization. Fifty-five presented with non-fluent 
aphasia and 48 were fluent. Aphasia type was determined by the WAB-R. For 
reliability data from 44 of the 103 individuals with aphasia were used to 
examine internal reliability and external validity. Correlational analyses were 
conducted on all items across sentence types. Participant performance on all 
items on the VNT indicating a high degree of internal reliability. The same 
patterns were demonstrated in the SPPT and the SCT with significant 
correlations between all individual items. For interrater reliability, no 
significant differences were found across raters per subtest. (P=.919 -
p=.999). During the assessment of external validity, significant correlations 
were found between all NAVs subtests and WAB-R aphasia quotient scores. 
The NAVS appears to be a valid measure for verb and sentence 
comprehension and production.  
Correct Information Units/agrammatic profile (CIUS, Nicholas & 
Brookshire, 1993). The participants’ agrammatic profiles were determined for 
eligibility by using narrative speech samples from the elicitation materials from 
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Nicholas and Brookshire. To assess interjudge reliability, the two scorers who 
scored the transcripts for this study both independently scored a 
systematically selected, representative sample of the transcripts (10 speech 
samples for each of 6 non–brain damaged and 6 aphasic subjects). The 
aphasic subjects were representative of the group in severity and type of 
aphasia. Four of the subjects exhibited fluent aphasia and 2 exhibited 
nonfluent aphasia. Point–to–point interjudge percent agreement for number of 
words and number of CIUs was calculated with the following formula: [total 
agreements/ (total agreements + total disagreements] x 100]. Interjudge 
reliability exceeded 98% for words and 90% for CIUs for all 12 subjects and 
did not appear to be strongly correlated. Intrajudge reliability exceeded 99% 
for words and 95% for CIUs for all 6 aphasic subjects. 
Apraxia Battery for Adults-2 (ABA-2; Dabul, 2000). All participants were 
administered the ABA-2 (Dabul, 2000). The ABA-2 was administered to 
determine the presence or absences of speech, oral or limb apraxia.  
Reliability and Validity of the Apraxia Battery for Adults. Test 
reliability, investigated by the coefficient alpha, was rated as high (reliability 
coefficients of .83 to .99 were obtained for all subtests). Content, criterion-
related validity, and construct validity were studied through a review of the 
literature, item analysis, comparing the results of the ABA-2 to the Porch 
Index of Communicative Ability, comparing differences in scores on the ABA-
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2 of various subpopulations, and examining the correlations of the subtests. 
Results indicate that examiners can use the ABA-2 with confidence. 
Experimental Treatment Tasks  
Table 3.  
Counterbalanced Treatments per Participant 
P1 P2 
Script Therapy: weeks 1-9 VNeST: weeks 1-9 
VNeST: weeks 9-18 Script Therapy: weeks 10-18 
 
Procedures for Script Therapy Treatment   
Script Therapy Stimuli. Prior to the treatment phase, all participants 
worked in conjunction with the primary investigator to develop the three script 
topics including a hobby, a vacation and a phone call scenario. Each topic 
was meaningful, relevant, and matched to each participant’s communication 
level. The communication level was determined by the participants’ ability to 
produce short versus more complex sentences as well as word retrieval.  
  After the scripts were documented, three phases occurred for each 
participant to learn the script. First, the participant listened to the entire script 
as read aloud by the speech-language pathologist.  Second, each sentence 
or phrase or conversational turn was practiced repeatedly. Third, the 
conversation was practiced with the primary investigator while cues are 
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provided based on the participants needs. These cues include a written word 
cue, hearing the primary investigators’ voice during choral speaking, and 
watching oral motor movements (Cherney, Halper, & Kaye, 2011).  These 
cues faded over time so the participants practiced the conversation with the 
primary investigator, without cues, as in a real conversation. All participants 
practiced the three individualized scripts for three weeks each for a total of 
nine weeks. Additionally, all participants were asked to practice at least 30 
minutes a day, six days per week for a minimum practice time of three hours 
a week. The Script data per participant can be found in figures 1 & 2.  
Treatment structure for Script Therapy. Each participant was seen 
individually for two 60 minute sessions for nine weeks. Treatment sessions 
were structured to allow at least three 10-minutes episodes of practicing 
scripts, interspersed with approximately four brief periods of relaxed open 
conversation. At the beginning of each session, the participants were audio- 
and video-recorded while practicing the scripts or the targeted verb 
sentences. As the scripts became mastered, treatment sessions ended with 
approximately 10 minutes of conversation practice to promote flexible use of 
scripts. The home practice sessions were prescribed twice daily for 15 
minutes each during which the participants practiced their scripts via a tape 
recorder. The participants reported consistency of home practice weekly 
through daily text messages to confirm practice. 
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Blocked Practice. Scripts were trained one phrase at a time, using a 
blocked practice approach to promote acquisition. The cueing hierarchy 
consisted of clinician modeling the target phrase, clinician and participant 
modeling in unison, clinician and participant productions of the phrase in 
unison, clinician and participant productions of the phrase in unison with 
clinician fading participation, independent productions by the participants with 
written cues and no cues.  
Random Practice. When three phrases of scripts were produced 
independently without cuing or support with 90% accuracy, random practice 
of scripts will be initiated for these acquired phrases. First, the clinician 
randomly selected and pointed to cue cards used to train the phrases. 
Participants were instructed to produce each phrase only once before moving 
on to the next phrase. Feedback on the accuracy of speech sound production 
and articulator placement/positioning was provided in a summary fashion 
after each episode of random practice.  
Procedures for VNeST Stimuli Development 
 Stimuli consisted of 10 cards containing the names of 10 target verbs, 
six to eight cards for each verb containing three to four agents and three to 
four patients that formed three to four pairs related to each verb. Additionally, 
five cards containing the words who, what, where, when, and why and 12 
sentences for semantic judgment and 12 sentences containing the target verb 
broken into four categories: 
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A. correct (“The designer measures the room.”), 
B. inappropriate agent (“The infant measures the lumber.), 
C. inappropriate patient (“The chef measures the television”), 
D. thematic reversal (“The room measures the designer”) 
(Edmonds & Babb, 2011). 
VNeST was administered two times per week for two one hour 
sessions for a total of 9 weeks. During treatment, both participants were 
asked to produce orally three to four thematic pairs (e.g. carpenter and 
lumber) for a provided verb (e.g. measure). When the participants were 
unable to produce a word, written options on cards were provided. In this 
protocol, the participants were to generate three to four agent pairs, then the 
participants would read each agent-patient pair aloud (the verb was not read 
aloud) and  then chose one answer to a wh-question. During treatment, 
participants were asked to produce orally three to four thematic role pairs 
(e.g. carpenter and lumber) for a provided verb (e.g. measure). When they 
were unable to produce a word, written options on cards were provided (some 
appropriate and some foils). Participants were encouraged to provide at least 
one personal pair (e.g., dad/boat for drive), and responses could change from 
week to week. In the original protocol (i.e., Edmonds et al., 2009), after 
generating three to four appropriate agent-patient pairs, participants read 
each agent-patient pair aloud (the verb was not read aloud) and chose one to 
answer wh-questions about it (e.g. when, where, or why). Following the 
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protocol, when the participants were unable to produce thematic role pairs for 
a provided verb; they were allowed to write their responses. Criterion for 
ending treatment is met when participants produced a minimum of 24 relevant 
agent-patient pairs (80% accuracy) during treatment Step 1 (e.g., for 
measure, acceptable pairs could include chef/sugar, wife/windows, or 
designer/room).  
Treatment session structure for VNeST  
During administration, probe pictures were presented pseudorandomly 
with semantically related verbs (e.g.bake/fry) in non-sequential order. For 
each picture, participants were instructed to make a sentence and include 
him/her, the action, and this (while pointing to the agent [carpenter], verb 
[measure], and patient [stairs]). Prompts were not provided unless the 
participant produced a general word for the target (e.g. cut instead of slice or 
man instead of carpenter), for which a prompt for a more specific word was 
given. The VNeST data per participant can be found in figures 2. & 3.  
Post-Treatment Testing 
The measures assessed during initial testing were repeated during the 
post-treatment session immediately following the cessation of treatment. 
Tests results were analyzed from pre-to post treatment to address single 
lexical retrieval using the Western Aphasia Battery-Revised (WAB-R), the 
Boston Naming Test, (BNT; Kaplan, Goodglass & Weintraub,1983), the 
Northwestern Assessment of Verbs and Sentences (NAVS) (Thompson, 
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2002). Finally, to gauge lexical retrieval in connected speech were evaluated 
with 10 elicitation materials from Nicholas and Brookshire (1993).  
The participants underwent post-treatment testing to 1) To determine 
treatment gains in rate of speech or words per minute, subject-verb-object 
production or sentence level production and error rate or discourse, 2) 
Assessment generalization of untrained verbs in VNeST. 3) Assess changes 
in their Aphasia Quotient on the (WAB-R). Additionally, a four-week post-
treatment session was conducted to evaluate the maintenance of treatment 
gains in production of scripts and naming of trained subject, verb, and objects 
combinations in VNeST. 
Table 4.  
Post-Treatment Assessment Scores  
 WAB-R BNT 
N =60 
NAVS 
N=22 
CIUS CLQT ABA-2 
P1 69.9 44 17 15 190 
Attention, 
165 
Memory,  
33 
Executive 
Functions, 
22 
Language  
moderately 
severe 
score in 
language, 
98 
Mild 
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Visuospatial 
Skills  
 
P2 50.3 34 10 12 193 
Attention, 
185 
Memory,30   
Executive 
Functions, 
20 
Language  
severe 
score in 
language, 
89 
Visuospatial 
Skills   
 
WNL 
 
Treatment Fidelity 
 Treatment fidelity refers to the methodological strategies used to monitor 
and enhance the reliability and validity of behavioral interventions (Robey, 
2004). For script therapy, each participant was evaluated after each session on 
the following: percentage of script related words, number of morphemes, 
number of nouns, number of verbs, and number of modifiers. The VNeST data 
included the percentage of verbs, percentage of objects, percentage of 
subjects, the wh-questions, and semantic judgment. 
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Figure 2. Script Therapy data for P1. 
 
 
Figure 3. Script Therapy Data for P2. 
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Figure 4. VNeST Data for P1.  
 
 
Figure 5. VNeST Data for P2.  
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Reliability 
Reliability was determined for a number of measures by the author and 
three trained research assistants. Reliability was determined by dividing the 
number of responses agreed upon by the total number of responses scored.  
Pre-to-post-treatment language measures. Inter-rater reliability was 
conducted on pre-to-post treatment language measure. A reliability score of 
(0.97) was attained on all pre- and post- treatment measures. Scoring 
agreement was (0.92).  
Treatment. Three trained master’s level research assistants watched 
55% of all sessions to ensure adherence to treatment protocol. Inter-rater 
reliability scores were calculated for each of the variables. Approximately, 
60% of the probes from baseline, treatment, and maintenance phases were 
rescored by the three research assistants. Prior to the initiation of the study, 
the three research assistants were trained on Script and VNeST treatment 
protocols. The research assistants were also trained on the Systematic 
Analysis of Language Transcriptions (SALT; Miller & Iglesias, 2012). Using 
the Pearson Correlation Coefficient, agreement in responses, and scoring 
among three research assistants was (.94) on all post- testing measures.   
Treatment Reliability for Script. Pre-, Post- and maintenance Scripts 
were audiotaped and transcribed and compared with target Scripts for 
content, grammatical productivity, and rate of Script words produced. All 
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Scripts were transcribed by the primary investigator and one of the three 
master’s level research assistants. Inter-rater reliability of all script therapy 
sessions were rescored and transcribed independently by the three masters 
level research assistants which the score was (.93) using a Pearson Product 
Correlation Coefficient on all script variables.   
Treatment Reliability for VNeST. To ensure the VNeST treatment 
protocol was conducted consistently, the same three master level research 
assistants participated in 55% of all sessions. Treatment reliability was 
followed approximately (.95) using a Pearson Product Correlation Coefficient 
with the VNeST protocol. For inter-rater reliability, all VNeST sessions were 
rescored and transcribed independently by the three masters level research 
assistants which the agreement score in responses and scoring among two 
research assistants was (.91) on all VNeST variables.  
Measures 
Probe measures 
The probes measures consisted of short language samples including 
picture sequences/descriptions, short novel videos, and procedural 
narratives. All probes were randomly assigned during the second session of 
each week. For all probes a series of prompts were offered to help elicit more 
language. For each probe, participants were instructed to “make a sentence 
and include what he or she is doing in each picture, or tell me what is 
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happening, and please tell me more, tell me the steps involved in. A 
randomized list of six prompts for each probe were used throughout this 
study.  
Pre-, mid-, and post- treatment probes. Both participants were 
measured at pre- and post- treatment using picture narrative tasks from the 
Nicholas and Brookshire Picture cards.  The Cookie Theft Picture from the 
Boston Diagnostic Aphasia Examination (BDAE; Goodglass & Kaplan, 1972) 
was used to assess the mid-treatment probe. 
Pre-to-Post Treatment Measures (Dependent Variables) 
The dependent variables include rate of speech, subject- verb-object 
production (SVO), and error rate. Rate of speech was determined by words 
per minute. Addtionally, rate of speech is an example of a word level 
measure. Subject -verb- object (SVO) production was based on all sentences 
that contained the correct S-V-O structure (not including grammatical 
correctness- use of functor words). S-V-O production is an example of a 
sentence level measure. Error rates are an example of a discourse level 
measure. For error rates, this was determined by the number of paraphasias, 
(phonemic/semantic), repetitions, omissions, substitutions, I don't know 
responses/no responses, incomplete utterances, morphological errors, 
interjections (um), and perseverations. All outcome measures were assessed 
over a two-minute time period during probe tasks. The probe tasks consisted 
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of a short video that was viewed on an Ipad approximately two minutes in 
length, a picture sequence (3-4 pictures), or procedural narratives.  
The Independent variables included the two treatments of Script 
therapy and VNeST. The generalization of these variables was measured on 
the three dependent variables during the second session of each week. 
Risks and Benefits 
Participating in the study did not put the participants at any potential 
risk or discomfort. Participation did benefit the participants directly. 
Participation was completely voluntary and the participants had the choice to 
stop and withdraw from the study at any time.  
Ethical Considerations 
The principle investigator and three master’s level research assistants 
were the only individuals to have access to the participant videos and 
transcripts throughout the study and data collection.  
Equipment/Instruments: Video/Audio Taping 
All participant data were collected in the LaSalle University Speech-
Language-Hearing Community Clinics. Video and audio taping was collected 
using the Logitech Webcam software were used to record both video and 
audio sample of clients. An additional Sony Digital Voice recorder (ICD-
BM1VTP) were used to record all samples during sessions. The data was 
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collected via digital video and audio recorder at the beginning of each session 
and later transcribed. All videos, audio recordings, and transcribed samples 
were kept on a password protected external hard drive in a locked office. All 
collected data will be kept for at least 3 years after project completion. All 
participants were de-identified after they consent to the study by an alpha-
numeric code will be used in place of their names. The informed consent form 
will be the only place where their name appears and these will be locked in a 
file cabinet in an office to ensure no connection can be made between the 
subject and all data. After the participants consented to the study, they were 
assigned an alpha numeric code which was placed on all materials instead of 
their name. All data will be kept in locked in a file cabinet in which is password 
protected. The keys for the file cabinet were also under lock and key. All 
electronic video/audio tapes were stored on an external hard drive which was 
locked in a cabinet in the primary investigator’s office.  
Statistical Analysis 
 In this study, both dependent and independent variables were 
analyzed using SPSS statistic software version 24. 
  
 
 
 
 
57 
 
Chapter IV 
 
RESULTS 
 
Study Objectives 
 The objectives of the current study were to determine which of the two 
treatments: Script and/or VNeST were beneficial in the improvement of the 
word, sentence, and discourse level measures. 
Data Analyses 
 To answer the study predictions and research questions, the following 
statistical methods were used. The first analysis included the variability on the 
pre- and post-treatment scores from baseline to maintenance. Secondly, each 
of the three outcome measures: (rate of speech, SVO, and error rate) were 
analyzed from the baseline to maintenance stages to determine improvement. 
Third, using the Busk and Serlin’s (1992) d2 effect size formula, the outcome 
measures were evaluated according to the magnitude of change from 
baseline to maintenance tasks. Lastly, using the Percentage of Data 
Exceeding the Median Scores (PEM), both participants were evaluated for the 
effectiveness of the interventions.  
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Each research question and hypothesis is reiterated below, followed by the 
results for each question. 
1.) RQ1. Does the combination of Script and VNeST interventions 
improve language outcomes in individuals with chronic agrammatic 
Broca’s aphasia during standardized assessment measures? 
    H1a. Participants will increase language skills including naming, 
comprehension, narrative production and cognitive skill areas from pre-
treatment to post-treatment. 
2.) RQ2. Do the participants show gains in word level, sentence level, 
and discourse level measures obtained from baseline to maintenance 
phases? 
H2a. Participants will show gains in rate of speech, SVO production, 
and decrease error rates obtained from language samples at baseline 
through maintenance phases. 
3.) RQ3. What are the relative effects across interventions on word, 
sentence, and discourse level measures obtained from language 
samples? 
H3. Large effect sizes will be found on word, sentence, and discourse 
level measures across interventions. 
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3a.) RQ3a. What are the relative effects for each participant on 
word, sentence, and discourse level measures across interventions? 
  H3a Large effect sizes will be found on word, sentence, and 
discourse level measures for each intervention per participant   
 
4.) RQ4. How does Script compare to VNeST intervention for improving 
language outcomes in individuals with chronic agrammatic Broca’s 
aphasia? 
   H4a. VneST will be more efficient in improving language outcomes for 
the chronic agrammatic population. 
Analysis of RQ1. When analyzing the standardized assessment data, 
a percentage of change score was obtained. To evaluate standardized 
assessment data, both participants increased on the subtest of the WAB-R 
scores including auditory comprehension, fluency, repetition, and naming. 
P1’s aphasia quotient increased from 46.5 to 69.9. P2’s aphasia quotient 
increased from 42.5 to 50.3. On the BNT, P1’s scores increased from 31 to 
44 and P2’s score increased from 30 to 34.  Additionally, both participants 
increased on the confrontation naming task of the BNT scores, and the 
executive functioning scores on the CLQT. P1 increased her NAVS scores 
from 45% to 57%. P2’s pre- and post- NAVS score remained the same. On 
the NAVS, P2 had more difficulty with the verb production task and the 
argument structure task indicating that production of verbs was more difficult 
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for this participant.  P1 was able to slightly increase her CIUS with the 
procedural narrative tasks increasing from 4 to 5 words and her percentage of 
CIUS increased from 10 to 11 on the picture description tasks. Furthermore, 
P2 did not increase his CIUs production on picture sequencing tasks from 
pre- to post- treatment. Both participants were able to increase their language 
subtest scores on the CLQT language scores 15 to 22 and 11 to 20.   Please 
see Table 5 for full assessment data scores.  
Table. 5  
Descriptive Statistics for Pre- and Post- Treatment Assessment Data. 
 
 
 P1 P2 
 Pre Post Pre Post 
WAB-R 46.5 69.9 42.5 50.3 
BNT 
 
31 44 30 34 
NAVS 45% 57% 38% 38% 
CIUS 4,10,4 5,11,5 3,9,4 4,10,4 
CLQT  15 22 11 20 
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Figure 6. Rate of speech for P1 and P2 from baseline through maintenance 
phases. 
P1 rate of speech increased from 19 to 40 (WPM; words per minute) 
from baseline to maintenance phases. P1 demonstrated an upward trend 
throughout the study, except during the washout period. She received Script 
therapy and then VNeST interventions. P2 received VNeST and then Script 
interventions. P2’s rate of speech increased from 11 to 31 WPM from 
baseline to maintenance phases. Also, P2 exhibited a decrease in rate or 
WPM during the washout period as P1. Overall, P2’s rate of speech did 
increase but not as significantly as P1’s rate. 
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Figure 7. Sentence-Verb-Object (SVO) production per participant across 
baseline to maintenance phases 
Both participants increased SVO production from baseline to 
maintenance phases. During the washout period, both participant exhibited 
the same decline in SVO production as with rate of speech.  P1’s SVO 
production increased from 3 to 9 SVO productions from baseline to 
maintenance phases. P2’s increased from 4 to 5 SVO productions from 
baseline to maintenance phases. Similarly, P2’s SVO production did increase 
but not as much as P1’s. Also, with the rate of speech measure, SVO 
production also decreased with both participants during the no-intervention 
phase.  
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Figure 8. Percentage of error per participant from baseline to maintenance 
phases. 
Error rates for both participants remained high throughout the study. 
P1’s error rate decreased from 46% to 21% from baseline to maintenance. 
P2’s error rate increased from 39% to 52% from baseline to maintenance. 
Both participants’ error rates were the highest during the no intervention 
phase.  
Analysis of RQ2. Given the order of treatments, both participants 
increased their word level measures or rate of speech, SVO or sentence level 
measures and P1’s error rate or discourse level measure decreased from the 
baseline to maintenance phases. These results indicate that both 
interventions were effective for P1 and P2 at the word and sentence level. As 
for error rate, only P1’s error rate decreased from pre-to-post treatment. For 
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P2, his error rate increased from baseline to maintenance phases.  The 
effectiveness of these treatments can be seen during the no intervention 
phase where all outcomes either decreased or increased for these 
participants. In summary, during the intervention phases both participants 
benefitted from these treatments.  
Analysis of RQ3. To evaluate RQ3. (magnitude of change from 
baseline to maintenance), effect sizes (d2; Busk & Serlin, 1992), were 
calculated to get to get an “index of durability” (Beeson & Robey, 2006, 
p.167). A meta-analysis of aphasic treatment studies by Robey and Beeson 
(2006) resulted in benchmarks of 4.0, 7.0, and 10.1 for small, medium, and 
large effects so these numbers are used to aid interpretation of the results. 
Table 6.  
Effect sizes from baseline to maintenance phases  
 P1 P2 
Rate of Speech 40-21/3.93)= 4.83 
Small effect 
(26.67-12.33/3.36)=4.27 
Small effect 
 
SVO Production (8.66-3.66/0.57)=8.77 
Medium to large effect 
(4.33-3/1.07)=1.24 
Relatively no effect  
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Error Rate (25-40/4.44)=3.37 
Relatively no effect 
(51-37/3.02)=4.63 
Small effect 
 
 
Busk and Serlin  
  
d2=x−A2−x−A1 
spooled 
 
Figure 9. Busk & Serlin’s (1992) Equation for calculations of effect sizes.  
Beeson and Robey (2006) explained that Busk and Serlin’s d2 (1992) 
effect size formula is beneficial in single subject designs such as this study. 
Busks and Serlins’ (1992) formula states that A2 and A1 designates 
maintenance and pre-treatment periods, respectively, x̄ A is the mean of the 
data collected in a period, and spooled is the square root of the weighted 
average of the variances for A1 and A2. 
According to the Beeson and Robey (2006) benchmarks, the effect 
sizes for rate of speech or word level measures were (d2 = 4.83; d2 = 4.27 
WPM) indicating a small effect for WPM for both participants. For SVO 
production or sentence level measures, P1 yielded an effect size of (d2 = 
8.75) indicating a medium to large effect. P1 increased her SVO combinations 
from 4 to 9 by the maintenance phase. P2’s SVO production yielded little to 
no effect (d2 = 1.02). For error rates, the effect sizes were calculated using 
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absolute value since the two treatments were designed to decrease an 
undesirable behavior rather than increase a desirable behavior (Beeson & 
Robey, 2006).  
On discourse level measures, P1’s error rate yielded little to no effect 
(d2 = 3.37). This effect size for error rate was interesting in the fact that P1’s 
error rate did decline from the baseline to maintenance phases. Furthermore, 
P2’s error rate yielded a small effect (d2 = 4.63) indicating that error rates did 
increase by 5 errors per probe from baseline to maintenance phases. 
Analysis of RQ3a. Using the Percentage of Data Points Exceeding 
the Median (PEM) scores, Ma (2006) created another way to evaluate data 
interventions. For intervention studies focusing on increasing behaviors, Ma 
(2006) suggested that reviewers draw a median line for the baseline data and 
calculate the percentage of data points in intervention that fall above the 
median line for behavior reduction studies, then percentage of data points 
below the median line should be calculated. Several strengths could be found 
in the PEM approach. First, there have been no reports of situations where 
PEM could not be used. Second, PEM has been shown to be correlated with 
author judgments of intervention effectiveness (Ma, 2006). The null 
hypothesis of the PEM approach is that if the treatment has no effect, the 
data points in the treatment phase will fluctuate up and down around the 
middle line. The data points have 50% of chance of being above and 50% 
chance of being below the median of previous baseline phase. The PEM 
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score has a range of 0 to 1. The PEM score has the same meaning as the 
effect size. One can compute one PEM score from each pair of baseline 
treatment phases. One can further calculate the overall mean effect size of 
each article or the mean effect size of each variable category. 
Table 7. 
Score Ranges for PEM interventions.  
PEM Score Ranges 
.9 to 1 Highly Effective Treatment 
.7 to .9 Moderately Effective Treatment 
< .7  Questionable or Ineffective Treatment 
 
 
Figure 10. PEM data for P1 for Rate of Speech during Script and VNeST. 
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P1’s PEM score for rate of speech yielded a score of 19 words per 
minute at baseline which means that Script Therapy (PEM score = .78) which 
indicates that Script was moderately effective. A PEM score of (1) on VNeST 
indicates that this therapy was highly effective for this participant.  
 
Figure 11. PEM data for P1 for SVO production during both Script and VNeST  
For P1, Script therapy (PEM = .78) was moderately effective in the first 
nine weeks on the SVO outcome measure. Additionally, P1’s score of (PEM = 
1) during VNeST therapy means that this therapy was highly effective.  
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Figure 12. PEM data for P1 for Error Rate during both Script and VNeST 
P1’s PEM scores were (.67) for Script indicating a questionable effect 
and (.78) VNeST interventions indicating moderately effective on the outcome 
measure of error rate.  
 
Figure 13. PEM data for P2 for rate of speech during VNeST and Script 
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For both VNeST and Script treatments, P2 exhibited PEM scores of (1 
& 1) indicating that both treatments were highly effective on rate of speech.  
 
Figure 14. PEM data for P2 for SVO production during VNeST and Script 
For VNeST, P2’s PEM score was (.44) indicating that this treatment 
was ineffective. For Script therapy, P2’s PEM score (1) indicated that Script 
therapy was highly effective. 
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Figure 15. PEM data for P2 for Error Rate during VNeST and Script 
P2’s PEM score was (.11) on VNeST and (.44) on Scripts indicated 
that neither treatment was effective for error rate. 
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Table 8. 
Summary Table for Effect Sizes and PEM Scores for P1  
 
Table 9.  
Summary table for effect sizes and PEM scores for P2 
 
P1 
Script VNeST
PEM PEM
Baseline to 
Maintenance
Effects
Rate of 
Speech
.78
Moderately effective
1
Highly effective
4.83
Small effect
SVO .78
Moderately effective
1
Highly effective
8.77
Medium to large effect
Error rate .67
Ineffective 
.78
Moderate effect
3.37
No effect
P2
VNeST Script 
PEM PEM
Baseline to 
Maintenance
Effects
Rate of 
Speech
1
Highly effective
1
Highly effective 
4.27
Small effect 
SVO .44
Ineffective 
1
Highly effective 
1.24
No effect 
Error rate .11
Ineffective 
.44
Ineffective 
4.63
Small effect 
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         Summary analysis (RQ4.) When analyzing the baseline to 
maintenance effects, and PEM scores, both participants demonstrated 
variability on outcome measures across interventions. P1 exhibited a small 
effect for Script therapy on the outcomes measures. For VNeST, P1 
demonstrated a greater change for SVO production. After analyzing baseline 
to maintenance effects, P1 demonstrated small effects for rate of speech and 
medium to large effects or change for SVO. P1 produced more limited effects 
during both interventions. The PEM scores for VNest do prove this 
intervention was beneficial for P2. A small effect was noted for rate of speech 
during Script therapy. PEM scores did show that Script therapy was effective 
for rate of speech and SVO for P2 .For baseline to maintenance effects, a 
small effect was noted for rate of speech and error rates. P2’s error rate did 
change but actually increased from baseline to maintenance probes.   
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Chapter V 
 
DISCUSSION 
 
The aim of this study was to assess whether one treatment: Script or 
VNeST was more beneficial for participants with agrammatic Broca’s aphasia 
and to determine the effects on outcome measures at the word, sentence, 
and discourse levels. Also, to determine whether a combination of the social 
functional and impairment specific approaches are most effective for this 
population and to explore the use of a single subject multiple-baseline 
alternating treatment across participants’ design. 
Study Predictions 
  It was predicted that the participants would demonstrate an increase 
in rate of speech and SVO production through the study. Another prediction 
was that error rates would decrease over the course of both treatments.  
Overall Results of Interventions 
 Both participants benefitted from the interventions in this study even 
though they were considerably post-incident at 20 and 26 months. The 
participants made considerable gains on the outcome variables. 
Validity of standardized assessment measures 
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 Pre- and post-treatment and descriptive data demonstrated that the 
participants were similar across demographic and assessment scores. The 
overall results showed different responses across participants with P1 
exhibiting greater effects than P2. The results of the pre-and post-treatment 
measures were similar to previous studies have established that traditional 
linguistic or impairment specific approaches have an effect on impairment 
measures such as the WAB-R, NAVS, CLQT, CIUS and BNT (Edmonds et 
al., 2009, Edmonds & Babb, 2011, Beeson & Robey, 2006). Both participants 
with agrammatic Broca’s aphasia benefitted from the two treatment 
approaches based on post-treatment assessment scores. Based on the post-
treatment results, these assessments are useful for validating the 
interventions as well as providing quality linguistic and cognitive data for 
individuals with agrammatic Broca’s aphasia. Furthermore, examining the 
effect sizes can help determine if the interventions were beneficial and PEM 
data can show the variability of both interventions per participant.  
Effect Sizes  
Baseline to Maintenance Effects 
  For rate of speech, P1 and P2 yielded small effect sizes (P1: d2 = 
4.83; P2: d2 = 4.27) based on baseline to maintenance phases. For SVO 
production, P1 produced a medium to large effect (P1: d2 = 8.75). P2 
demonstrated relatively no effect for SVO production with a small effect (P2: 
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d2= 1.02). For error rate, P1 produced relatively no effect of (P1: d2 = 3.37). 
P2 produced a smaller unfavorable effect for error rate (P2: d2 = 4.63). 
 After analyzing the effect size outcomes, it is important to note that the 
Beeson and Robey benchmarks (4.0,7.0, and 10.1) are set as framework for 
aphasia research. Additionally, these effect size values provide a means to 
compare treatment outcomes within and between individuals, as well as to 
compare the relative strength of various treatments for aphasic populations 
(Beeson & Robey, 2006).  
 In this study, the participants did demonstrate improvements, despite 
small effect sizes indicating that these therapies were useful in producing 
change for the agrammatic Broca’s aphasia.  
Percentage of Data Exceeding the Median (PEM) 
 In general, the effect sizes were not always consistent with the PEM 
results per participant. The PEM scores can help validate effective 
interventions and can contribute to the strength of the effect size scores (Ma, 
2006). It is important to note that PEM evaluates a potential change or 
variation of scores across treatment and probe assessment sessions.  P1’s 
PEM score for rate of speech during Script was moderately effective. For 
VNeST, P1’S PEM score was highly effective. P2’s PEM rate of speech score 
was very effective for both treatments. For P1, Script therapy PEM score was 
moderately effective in the first nine week SVO production. P1’s VNeST PEM 
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score was very effective for SVO production. For P2, SVO PEM score was 
moderately effective for VNeST and highly effective for Script. For error rate, 
P1’S PEM score was ineffective with script and moderately effective for 
VNeST. P2’s PEM score for error rate for both interventions were scored as 
ineffective.  
Effectiveness of the Interventions by outcome measure 
 Based on the effect sizes and inter-therapeutic PEM scores, both 
interventions Script and VNeST were found effective in treating at the word 
and sentence levels for these participants with chronic agrammatic Broca’s 
aphasia. VNeST was considered more effective for both participants for rate 
of speech based on PEM scores. Script was considered most effective for 
SVO productions based on inter-therapeutic PEM scores. Finally, neither 
intervention was considered effective for error rate. For P1, VNeST was more 
effective than Script during the therapeutic phase of study on all outcome 
measures. Script Therapy was more effective on rate of speech and SVO 
production during the therapeutic phase of the study for P2. 
 Given the participants status post stroke, perhaps they have to live 
with some errors in speech at the sacrifice of clearer communication. In the 
future, it may be possible to isolate the error patterns and provide an 
alternative type of therapy that would address specific errors per participant. 
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Effectiveness of the Interventions per participant 
 After summarizing the effect sizes, and PEM scores, it appears that 
both treatments were successful for P1 and P2 performance in individual 
ways. VNeST involves the activation of large semantic networks that can 
potentially result in generalization to lexical retrieval. (Edmonds et al., 2009). 
Theoretically, generalization to outcome measures should occur if other, more 
complex measures are also to improve. This appears to be the case for P1, 
she improved over the course of the 18 weeks with the outcome measures; 
however, her error rate decreased with no effect. For P1, she demonstrated 
generalization on the outcome measure of rate of speech across the course 
of the 18 weeks. Additionally, she increased on all pre-to-post treatment 
assessment measures. She presented with morphological errors, repetition 
errors, and articulation errors due to apraxia, but her word retrieval was better 
for semantic networking. P1 was rated as mildy apraxic so having phonemic 
errors are consistent her diagnosis of agrammatic Broca’s aphasia and 
apraxia. Additionally, P1 did suffer seizures after the stroke with which she 
was currently being medicated and the impact of the medication Gabapentin 
may have impacted her performance during the study. 
 Although, P2 presented with more limited generalization on outcome 
measures, there were many indications for clinical improvements. First, he 
increased his pre-to-post treatment assessments scores except for the NAVs 
and CIUs. It is not completely clear as to why P2 did not improve to the extent 
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that P1 did throughout the study. Both participants did improve over the 
course of the study but P1’s effect sizes from baseline to maintenance 
demonstrated a greater magnitude of change. First, it is possible that the time 
between P2’s stroke and the start of the study could have attributed to the 
second participants level of performance. Secondly, P2 had slightly lower 
scores on the assessments than P1. P2 presented with slightly lower scores 
on the comprehension portions of the WAB-R, CLQT (Auditory 
Comprehension portion), and the NAVS (verb comprehension subtest).  P2’s 
processing and retrieval speed was also more reduced than P1. Furthermore, 
P2 presented with a dysarthric speech pattern that was different than P1. In 
P2’s case history, he was diagnosed with depression after his stroke and was 
being treated with Zoloft an anti-depressant medication. Both participants had 
a similar cognitive profile for the CLQT. However, in-depth testing for 
cognition including working memory, attention, and other executive 
functioning abilities was not assessed during this study and could affect the 
response to treatment. P2 was more chronic in terms of word retrieval and 
types of errors. P2’s wife said he was more willing to attempt SVO phrases at 
home with prompting than prior to the study. P2’s errors included phonemic 
and semantic paraphasias, morphological errors, and perservations. 
 Despite differences in generalization across participants and 
interventions, both participants’ post-treatment error patterns showed an 
evolution of responses that suggest differences in processing and lexical 
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retrieval during interventions. Across the tasks, P1 made more attempts at 
production and her post-treatment errors were more motor planning errors 
consistent with the apraxia diagnosis. For P2, presented more with lexical 
retrieval errors.  
 Other factors that can also contribute to the generalization across 
participants and the interventions include the intensity of the treatments, the 
impact of impairment specific and social functional approaches, 
communicative intent, differences in gender, and the order of interventions.    
Intensity of therapy 
  In accordance with the pre-and post-treatment scores, the intensity of 
the therapies and the length of the study (two times per week for 18 weeks) 
could be another factor in the overall improvements on the treatment effects 
and outcome measures. Both Script and VNeST treatment protocols are 
based on nine weeks of treatment with two-one hour sessions per week 
(Cherney, 2010; Cherney et al., 2008; Cherney et al., 2011, Edmonds & 
Babb, 2011; Edmonds et al., 2014). This study’s treatment was consistent 
with Robey’s (1998) meta-analysis which demonstrated that the minimum 
intensity of aphasia therapy that affected change equaled two hours per week 
for chronic aphasics. 
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Impairment Specific vs. Social Functional 
  Given the fact that Script therapy is a social functional approach and 
that VNeST is an impairment specific approach, it is seemed counterintuitive 
that P1 and P2 exhibited such widespread gains. There are a number of 
factors that would predict potential improvements with this population. First, 
VNeST allows for the training of verbs, subjects, and objects which is the 
foundation needed for sentence production (Edmonds, et al., 2009; Edmonds 
& Babb, 2011). Second, VNeST is a semantic treatment that focuses on 
lexical, semantic, and phonological activation so theoretically during all 
phases of VNeST each area is activated (Edmonds et al., 2009). Nickels 
(2002) explained that individuals with impaired phonological, semantic, and 
lexical levels seem to benefit from tasks that combine semantic networking 
and activation. Additional areas such as the communicative intent, gender 
differences and the order of the interventions all can contribute to the 
effectiveness. 
Communicative Intent 
  Unlike VNeST, Script Therapy focuses on retraining phrases of fluent 
automatic speech. This promotes personal functional sentence production for 
individuals with aphasia and apraxia of speech. Script therapy focuses on a 
social approach to communication. Additionally, the use of Scripts allowed 
these participants to tailor their intentions for communication. P1’s intention 
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for communication involved being able to have a repertoire of phrases that 
she could use with her daughter’s pre-school teacher. For P2, he wanted to 
be able to have a phone conversation with long-distance family members.  
Gender Differences 
 Males have a higher significance of morbidity for aphasia than females 
(69.90% to females 42.97%) especially after stroke (Yao et al., 2015). Broca’s 
aphasia was reported as the most common type of aphasia for both male and 
female (29.01% and 24.22%). For the participants in this study, it was 
conclusive that the male participant exhibited greater impairment in 
communication than the female participant which was consistent with 
previous research findings.  
Order of Interventions 
 Based on the data for P2, this participant benefitted from receiving 
VNeST therapy first and then Script Therapy. For this participant, the VNeST 
treatment acted as a priming effect for this participant. A similar result was 
found in Edmonds and Babb (2012).  P1 improved on all dependent variables 
from Script Therapy to VNeST therapy. It seems that P1 benefitted from both 
intensity of therapy and the Script treatment then VNeST. It was hypothesized 
that P1 had more predicted motor planning issues due to the apraxia than 
word retrieval deficits. For P2, it seemed that VNeST helped with the 
activation of the semantic, phonological, and lexical retrieval which helped 
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possibly with the activation of the executive function areas such as memory, 
initiation, and recall (Fridrickson, Nettles, Davis, Morrow & Montgomery, 
2006). 
Effectiveness of study design 
  The use of the multiple baseline single subject alternating treatment 
across participants’ design offered the ability to look at the individual 
variability with the outcome measures, error types, and account for individual 
variances. It was predicted that single subject designs are less concerned 
with trends and help to increase internal validity and generalizability to real 
world clinical applications for specific populations like agrammatic Broca’s 
aphasia (Schwartz, 2010; Olswang, 1993; Beeson & Robey, 2006). 
Additionally, effectiveness studies or treatment outcome research can 
evaluate the effects of efficacious treatments across broader, more typical 
populations and under broader, more typical clinical conditions (Olswang, 
1993). These designs foster treatment outcome changes during or after the 
treatment process and addresses a variety of questions including cost of 
treatment, quality of care, and achievement of functional change in the client 
(Olswang, 1993). 
Clinical Implications 
Clinical Feasibility   
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 Based on the outcomes of this study, both treatments can potentially 
benefit the agrammatic Broca’s aphasic population. Both treatments, Script 
and VNeST, can be easily administered by speech-language pathologists, 
they are cost effective and have a high treatment intensity that is necessary 
for chronic aphasics. Additionally, the use of an impairment specific treatment 
in combination with a social functional treatment can better target the 
agrammatic Broca’s aphasics ability to access fluent and accurate language 
and can have tangible and psychosocial benefits.  
Limitations 
 Although the present study has yielded some preliminary findings, 
there were some limitations. These limitations included possible treatment 
effects of the 18-week treatment. Treatment fatigue due to the longevity of the 
study. There were a limited number of participants recruited due to the type of 
aphasia and the length of the study. Statistical challenges included the small 
number of participants, the use of non-parametric statistics, and possible 
order effects on outcome measures.  In the data analysis, there was limited 
ability to generalize results due to the small sample size and the convenience 
of the sample. Furthermore, the findings of the study can be generalized to 
the population of agrammatic Broca’s aphasia. Nevertheless, aphasia is a 
multifaceted condition with each individual presenting with different symptoms 
and levels of severity. 
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     Chapter VI 
 
CONCLUSIONS 
 
 This chapter highlights the results of the current study and the 
conclusions drawn regarding the outcome measures and the treatment 
approaches. Moreover, the need for future research is outlined.  
Conclusion 
 Severity of aphasia and individual participants' characteristics impact 
the relationship between intensity and improvement (Lee et al., 2009). P2 had 
a different intention to communicate than P1. People with aphasia choose to 
speak about their life experiences, choose to reconnect with their families, 
and tend to focus on communication that can help them to negotiate 
mundane normal life. Independent of how this content is used in treatment, 
materials should emphasize matters of high personal relevance to those 
treated (Holland, Halper & Cherney, 2010).  
 It is possible that the multi-modal nature of the training between 
VNeST and Script helps promote functional sentence production and a 
linguistic approach for sentence production contributed to a positive language 
change for both participants (Edmonds, Nadeau,& Kiran, 2009; Edmonds & 
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Babb, 2011, Edmonds, Mammino, & Ojeda, 2014; Cherney, Halper, Holland, 
& Cole, 2008).       
 P2 did exhibit difficultly initiating language more so than P1. It seemed 
beneficial for this participant to have a scripted inventory of phrases that he 
could use. 
P2 had an easier time finding the correct words, but would often have 
difficulty and either perseverate or produce phonemic paraphasias. P1 
presented with more anomic responses so she often said she didn’t know or 
produced repetitious responses. 
Future Directions 
  This study is a contribution to clinical practice in aphasia. Results such 
as those in the present study will hopefully advance the knowledge on 
treatment options and serve as a basis for applying an impairment specific 
treatment and social functional treatment for individuals with agrammatic 
Broca’s aphasia. This study also demonstrated the benefits of using a 
multiple- baseline across participants design with this population from a cost 
and benefit perspective. Also, the two treatments in this study can help 
speech-language pathologists help deliver beneficial, cost effective, and 
feasible care to their patients.  
 Future areas of research could involve more participants, possibly 
implementing VNeST first for the first treatment and then alternating with 
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another social functional approach like Script or a Supported Conversation 
Treatment.  
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APPENDIX B 
 
HACKENSACK UNIVERSITY MEDICAL CENTER IRB APPROVAL 
 
 
  
  
NOTIFICATION OF APPROVED EXPEDITED CONTINUING REVIEW 
   
From: Robert Krugman, MD  
To: Maureen Costello-Yacono  
CC: 
  
 
  
 
Re: 
Continuing Review # CR00003707 for Study#: Pro00006239  
Study Title:  2017 Review for Pro00006239  - Comparison of Two 
Treatment Approaches for Agrammatic Aphasia  
Expiration Date: 4/26/2018    
This is to advise you that the above referenced Study has been presented to the 
Institutional Review Board for Expedited Review.  
Please be reminded that all modifications to approved projects must be reviewed 
and approved by the Institutional Review Board before they may be implemented.  
Any changes to this protocol must be submitted for IRB approval before initiated. 
  
All Serious adverse events and unexpected adverse events must be reported to 
Institutional Review Board within seven days. 
   
Please do not make any changes to the IRB approved consent without approval of 
the IRB.  Only the IRB stamped approved consent should be used. 
  
If your study meets the definition of a qualifying study that meets the FDAAA 801 
definition of an "applicable clinical trial", you are responsible for ensuring that the trial has 
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been registered properly on the Clinical Trials.gov website prior to the enrollment of any 
subject.  
  
"Applicable clinical trials" generally include controlled clinical investigations, other than 
phase 1 clinical investigations (with one or more arms) of FDA-regulated drugs, biological 
products, or devices,  that meet one of the following conditions: 
•         The trial has one or more sites in the United States 
•         The trial is conducted under an FDA investigational new drug application or 
investigational device exemption 
•         The trial involves a drug, biologic, or device that is manufactured in the United 
States or its territories and is exported for research 
 
For complete statutory definitions and more information on the meaning of "applicable 
clinical trial," see Elaboration of Definitions of Responsible Party and Applicable Clinical 
Trial (PDF).  
  
It is necessary that you utilize the assigned protocol number in any and all 
communication submitted to the IRB office, i.e. amendments, audits, etc. 
  
  
This renewal has been approved via expedited review on 4/27/2017. 
  
  
  
   
  
Important news about our email communications.  
Hackensack Meridian Health Network has implemented secure messaging services. If you need assistance 
with retrieving a secure email, please send an e-mail to 
postmaster@hackensackmeridian.org 
 
Confidentiality Notice: 
This e-mail message and any attachments from Hackensack University Medical Center are confidential and for the sole use of the 
intended recipient. This communication may contain Protected Health Information ("PHI"). PHI is confidential information that may only 
be used or disclosed in accordance with applicable law. There are penalties under the law for the improper use or further disclosure of 
PHI. If you are not the intended recipient of this e-mail or the employee or agent responsible for delivering the communication to the 
intended recipient, then you may not read, copy, distribute or otherwise use or disclose the information contained in this message. If you 
received this message in error, please notify us by telephone at 551.996.2000 or by e-mail to postmaster@hackensackmeridian.org. 
Please indicate that you were not the intended recipient, and confirm that you have deleted the original message. Please do not retransmit 
the contents of the message. Thank you. Hackensack Meridian Health Network is the proud recipient of Quality New Jersey's Governor's 
Gold Award for Performance Excellence  
 
Hackensack Meridian Health Network 
30 Prospect Avenue Hackensack, New Jersey 07601  551-996-2000 
Copyright © 2016 Hackensack Meridian Health Network 
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                    APPENDIX D     
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APPENDIX E 
 
INTERVENTION TABLES 
 P1 P2  
Baseline outcome 
measure assessment  
Randomized 
probe/outcome 
measures 
Randomized probe/outcome measures 
Week 1; Session1 Scripts Development VNeST Stimuli Development   
Week 1; 
Session 2 
Script Development VNeST 
Stimuli Development   
Week 2; Session 1 Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week2: 
Session 2 
Treatment of Scripts 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 3; Session 1 Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 3; Session 2 Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 4; 
Session 1 
Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 4; Session 2 Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 5; 
Session 1 
Treatment of Scripts 
(60 minutes) 
P1 
Treatment of Trained Verbs (60 minutes) 
 
P2 
Week 5; Session 2 Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 6: 
Session 1 
Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 6;  
Session 2 
Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
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Week 7; 
Session 1 
Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 7; 
Session 2 
Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 8; 
Session 1 
Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 8; 
Session 2 
Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Week 9; 
Session 1 
Treatment of Scripts 
(60 minutes) 
Treatment of Trained Verbs (60 minutes) 
Week 9; 
Session 2  
Treatment of Scripts 
(60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Trained Verbs (60 minutes) 
Probe/Outcome measure assessment   
Session 9.5 Cookie Theft Pictures 
to assess 
Narrative story retell  
Two week break 
between treatments  
  
 PARTICIPANTS 
SWITCHED THERAPY  
PARTICIPANTS SWITCHED THERAPY 
Week 10; 
Session 1  
VNEST Stimuli 
Development 
  
Script Development  
Week 10; 
Session 2  
VNEST Stimuli 
Development  
Script Development  
Week 11; 
Session 1 
VNest 
Stimuli Development 
Script Development 
Week 11; 
Session 2;  
Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
Week 12; Session 1 Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 12; Session 2 Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
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Week 13; Session 1 Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 13; Session 2  
 
Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
 
Week 14; Session 1 Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 14; Session 2 Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
Week 15;  
Session 1 
Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 15; 
Session 2 
Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
 
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
Week 16;  
Session 1 
Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 16; Session 2 Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
Week  17; Session 1 
 
Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 17; Session 2 Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
Week 18; Session 1 Treatment of Trained 
Verbs (60 minutes) 
Treatment of Scripts (60 minutes) 
Week 18; Session 2 Treatment of Trained 
Verbs (60 minutes) 
Probe/Outcome 
measure assessment   
Treatment of Scripts (60 minutes) 
Probe/Outcome measure assessment   
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Post-Treatment 
Assessments   
WAB-R, BNT, CLQT, 
CIUS, NAVS, ABA-2 
WAB-R, BNT, CLQT, CIUS, NAVS, ABA-2 
Maintenance Phase: 
4 weeks after study 
completion  
Probes/outcome 
measures  
Probes/outcome measures 
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APPENDIX F 
 
SCRIPT TRAINING PROTOCOL 
Minutes Plan 
1-15 minutes Open period of conversation –Review of 
today’s goals  
15-25 minutes Practice 1 Script  
25-35 Practice 2nd Script  
35-45 Practice 3rd Script 
45-60 Review goals for session and homework 
practice  
 
• For Script therapy,  a review of the Script will be acquired and then the outcome 
measures of sentence production ,fluency of discourse and, rate of speech will be 
obtain at every session 
Mastery of 3 Scripts:  
1.) Hobbies 
2.) Vacation  
3.)Phone call  
Treatment structure for Script Therapy. Each participant will be seen individually for 
two 60 minutes sessions for 9 weeks. Treatment sessions will be structured to allow at 
least 3 10-minutes episodes of practicing Scripts, interspersed with approximately 4 
brief periods of relaxed open conversation. At the beginning of each session, the 
participants will be audio and video recorded while practicing the Scripts or the 
targeted verb sentences. The participants will be recorded during this data collection. 
As Scripts became mastered and entered a random practice phase, treatment sessions 
will end with approximately 10 minutes of Script conversation practice to promote 
flexible use of Scripts. The home practice sessions will be prescribed twice daily for 
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15 minutes each during which the participants practiced their Scripts via a tape 
recorder. 
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APPENDIX G 
 
VNeST Treatment Protocol  
Basic Daily Treatment Structure for VNeST (60 minutes) 
Minutes Plan 
1-15 minutes Open period of conversation –Review of 
todays goals  
15-25 minutes Practice 8 trained verbs  
25-35 Practice 8 trained verbs 
35-45 Practice 8 trained verbs 
45-60 Review goals for session and homework 
practice  
 
VNeST Stimuli Development. Stimuli will consist of 10 cards containing the names of 
10 target verbs, six to eight cards for each verb containing three to four agents and 
three to four patients that formed three to four pairs related to each verb. Additionally, 
five cards containing the words who, what, where, when, and why and 12 sentences 
for semantic judgment and 12 sentences containing the target verb broken into four 
categories: 
 A. correct (“The designer measures the room.”), 
B. inappropriate agent (“The infant measures the lumber.), 
C. inappropriate patient (“The chef measures the television”),  
D. thematic reversal (“The room measures the designer”) (Edmonds & Babb, 
2011).   
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VNeST will be administered two times per week for two one hour sessions for a total 
of 9 weeks. During treatment, all participants will be asked to produce orally three to 
four thematic pairs (e.g. carpenter and lumber) for a provided verb (e.g. 
measure).When the participants are unable to produce a word, written options on 
cards will be provided. In this protocol, the participants will generate three to four 
agent pairs, then the participants will read each agent-patient pair aloud(the verb was 
not read aloud)and  then chose one answer to a wh-question. Probes will presented 
during the beginning of each session (written or spoken). During treatment, 
participants will be asked to produce orally three to four thematic role pairs 
(e.g.,carpenter and lumber) for a provided verb (e.g.,measure). When they were 
unable to produce a word, written options on cards will be provided (some 
appropriate and some foils). Participants are encouraged to provide at least one 
personal pair (e.g., dad/boat for drive), and responses could change from week to 
week. In the original protocol (i.e., Edmonds et al., 2009), after generating three to 
four appropriate agent-patient pairs, participants read each agent-patient pair aloud 
(the verb was not read aloud) and chose one to answer wh-questions about it 
(e.g.,when, where,or why). Following the protocol, when the participants are unable 
to produce thematic role pairs for a provided verb; they are allowed to write their 
responses. Criterion for ending treatment is met when participants produced a 
minimum of 24 relevant agent-patient pairs (80% accuracy) during treatment Step 1 
(e.g., for measure, acceptable pairs could include chef/sugar, wife/windows, or 
designer/room).  
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 Treatment session structure for VNeST. Probe and control measures will be 
administered at the beginning of each session. During administration, probe pictures 
will be presented pseudorandomly with semantically related verbs (e.g.,bake/fry) in 
nonsequential order. For each picture, participants will be instructed to make a 
sentence and include him/her, the action, and this (while pointing to the agent 
[carpenter], verb [measure], and patient [stairs]). Prompts will not be not provided 
unless the participant produced a general word for the target (e.g.,cut instead of slice 
or man instead of carpenter), for which a prompt for a more specific word was given. 
Weekly probes will be administered in spoken and written modalities (on different 
days) to assess potential improvement in both modalities. For the control task, 
participants will be asked to complete sentences using a synonym for the provided 
adjective (e.g., Someone who is sick is also said to be _____[target =ll).In the event 
of multiple attempts, the adjective closest to the target will be scored.  
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APPENDIX H 
 
ERROR ANALYSIS 
 
 
SALT Error rate per session for P1: Probes 
Session PerseverationsIDK ParaphasiasIncomplete utterancesrepetitionsinterjectionsmorphological errorsomissions substitutions
1 2 6 3 2 1 3 3 1 0
2 3 4 6 5 2 2 5 0 1
3 2 4 4 1 2 2 3 0 0
4 5 3 9 7 9 4 5 2 1
5 3 3 4 1 9 2 10 0 0
6 3 1 1 2 5 1 8 2 1
7 2 2 4 1 1 3 2 2 0
8 0 0 3 1 2 2 2 0 1
9 3 2 6 1 1 0 2 4 2
10 2 3 3 2 4 0 0 4 0
11 3 1 3 1 1 3 4 2 1
12 1 2 4 1 1 2 2 3 1
13 4 0 3 4 2 4 4 2 1
14 14 2 8 9 2 3 11 0 2
15 11 6 10 11 2 6 2 0 1
16 5 3 6 0 2 6 5 3 3
17 0 0 5 4 2 3 3 2 1
18 14 0 3 1 1 0 11 1 0
SALT Error rate per session for P2: Probes 
Session PerseverationsIDK ParaphasiasIncomplete utterancesrepetitionsinterjectionsmorphological errorsomissions substitutions
1 3 0 6 1 4 0 0 0 0
2 4 0 5 2 3 0 3 0 0
3 5 0 6 4 2 0 7 0 0
4 5 0 4 0 2 0 5 0 2
5 4 0 7 3 2 0 6 0 0
6 5 0 6 0 1 0 5 0 0
7 6 0 5 1 2 0 4 3 0
8 7 0 4 0 3 0 6 1 2
9 6 0 12 0 0 0 5 2 2
10 4 0 8 5 2 0 11 2 0
11 3 0 9 4 0 0 4 0 2
12 4 0 6 2 0 0 4 0 4
13 6 0 5 4 3 0 7 3 0
14 6 0 4 4 0 1 6 0 1
15 8 0 4 2 3 0 7 0 7
16 4 0 5 3 2 0 4 0 1
17 3 0 4 2 0 0 3 0 1
18 7 0 8 2 0 0 8 0 3
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APPENDIX I 
 
SAMPLE SCRIPT 
  
Hobby Script #1 
C: What are some of your hobbies? 
P: I watch crime shows on TV.  
P: investigation  
C: What are these shows about? 
P: The show is about a detective investigating a crime  
C: What channel are these shows on? 
P: We have cable  
C: great 
P: I like it because I take criminal justice classes 
C: Oh, ok you took criminal justice classes in college 
P: yes, I studied criminal justice 
C: cool 
 P: I like these shows because you find out what the criminal did 
C: What was your favorite class in college? 
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P: I liked the forensic courses.  
 
 
 
 
 
 
